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During optic cup morphogenesis, the neuroectodermal layers of the optic vesicle 
(OV) invaginate ventrally, and fuse at the choroid fissure (CF) along the proximo-distal 
axis such that the retina and retinal pigment epithelium (RPE) are confined within the 
cup. Failure of CF closure results in colobomas, which are characterized by the 
persistence of a cleft or hole at the back of the eye. While CF closure is a critical aspect 
of ocular development, the molecular and cellular mechanisms underlying this process 
are poorly understood. My research examined CF closure and colobomas using zebrafish 
as a model system. In the first study, I determined that early cell fate changes within the 
eye field could cause colobomas using the zebrafish mutant blowout. Colobomas in 
blowout resulted from defects in optic stalk morphogenesis whereby the optic stalk 
extended into the retina and impeded the edges of the CF from meeting and fusing. 
Positional cloning of blowout identified a nonsense mutation in patched1, a negative 
regulator of the Hedgehog pathway. Up-regulation of Hedgehog pathway activity causes 
disruption in the patterning of the OV into proximal and distal territories, revealing that 
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cell fate determination, mediated by Hedgehog signaling, is intimately involved in 
regulating CF closure. In the second study, I examined Bcl6 function and regulation 
during zebrafish eye development. bcl6 encodes a transcriptional repressor expressed in 
the ventral retina during zebrafish eye development. Loss of Bcl6 function leads to 
colobomas along with up-regulation of p53, a previously known Bcl6 target, and an 
increase in the number of apoptotic cells in the retina, demonstrating that Bcl6 plays a 
critical role in preventing apoptosis in the retina during early eye development. I also 
showed that Vax1 and Vax2 act upstream of bcl6 in the ventral retina. Furthermore, I 
identified functional interactions between Bcl6, Bcor and Hdac1 during eye development, 
demonstrating that Bcl6 functions along with Bcor and Hdac1 to mediate cell survival by 
regulating p53 expression. Together my studies expand the gene regulatory network 
involved in cell fate determination and cell survival during CF closure and ventral retina 
formation, and provide mechanistic insight into coloboma formation. 
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INTRODUCTION – CHOROID FISSURE CLOSURE AND 
VENTRAL RETINA FORMATION 
 
I. 1. VERTEBRATE EYE DEVELOPMENT 
Vertebrate eye formation commences with the symmetric, bilateral evagination of 
optic vesicles (OV) from the diencephalon (Adler and Canto-Soler, 2007; Chow and 
Lang, 2001). Each OV then undergoes a complex series of morphogenetic movements 
that ultimately results in the formation of a bilayered optic cup, containing the 
prospective retina and retinal pigment epithelium (RPE). The optic cup remains attached 
to the diencephalon by the optic stalk, a transient structure that will eventually be filled 
by retinal ganglion cell axons and form the optic nerve. During optic cup morphogenesis, 
the neuroectodermal layers of the OV invaginate ventrally, and fuse along the proximo-
distal axis such that the retina and RPE are confined within the cup (Fig I-1). Fusion 
occurs along a distinct ventral region of the optic cup called the choroid fissure. The 
choroid fissure is also a transient structure that allows for the exit of retinal axons into the 
optic nerve, and for the entrance of the hyaloid artery into the eye. These major events are 











      Modified from Chang et al., 2006 
Figure I-1. The process of vertebrate eye development.  

















Modified from Fitzpatrick and van Heyningen, 2005.   




I. 2. COLOBOMAS 
Defects in choroid fissure closure result in colobomas; ocular malformations 
characterized by the persistence of a cleft or hole at the back of the eye (Fig. I-3) (Chang 
et al., 2006; Fitzpatrick and van Heyningen, 2005; Gregory-Evans et al., 2004). 
Colobomas have a relatively high rate of incidence, ranging from 2.6 in 10,000 births in 
the U.S., to 0.75 in 10,000 births in China and are the cause of 3-10% of childhood 
blindness worldwide (Hornby et al., 2000; Porges, 1995). Colobomas are a phenotypic 
manifestation in over 50 distinct human genetic disorders 
(OMIM:http://www.ncbi.nlm.nih.gov/) and are often associated with other congenital 
abnormalities in the eye, including microphthalmia and anophthalmia (Bermejo and 
Martinez-Frias, 1998), as well as those of other organ systems. Multiple subtypes of 
colobomas have been described and depending on their severity colobomas can at a 
minimum lead to cosmetic defects and more commonly, they lead to complete blindness. 
The most severe types of these are chorioretinal colobomas in which large regions of the 
eye lack both retina and RPE tissue because the cells that would have given rise to them 
were not enclosed within the developing optic cup. While choroid fissure closure is a 
critical aspect of ocular development that requires a precise interplay between growth, 
morphogenesis and regulated gene expression, the molecular and cellular mechanisms 














Figure I-3. Coloboma 
(A,B,C) Human eye pictures taken from the back of the eye. (E,F) Cartoon of human eye. 
(A,E) Normal eye with well contained retina tissue with eye cup. (B,C,F) Large holes in 
the back of the eye and lack of the large part of the retina tissue. (D) CT image from 
coloboma patient shows extrusion of retina tissue (red arrow).   
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I. 3. HEDGEHOG SIGNALING PATHWAY DURING EYE DEVELOPMENT 
Many developmental events in the OV are regulated by secreted signaling 
molecules of the Bone Morphogenetic Protein (BMP), Transforming Growth Factor Beta 
(TGF-β), Wnt, Fibroblast Growth Factor (FGF) and Hedgehog (Hh) families (Adler and 
Canto-Soler, 2007; Chow and Lang, 2001; Esteve and Bovolenta, 2006). Perhaps the best 
studied of these in early eye development is Hh, whose members regulate several aspects 
of OV formation, patterning and morphogenesis (Amato et al., 2004). Sonic hedgehog 
(Shh), secreted from the ventral midline, first functions in directing the separation of the 
eye field into two bilateral OVs in both mice and human embryos (Chiang et al., 1996; 
Roessler et al., 1996). In the zebrafish embryo, mutations in Shh do not lead to cyclopia 
likely due to redundancy with other Hh related proteins (Barresi et al., 2000; Karlstrom et 
al., 1999; Schauerte et al., 1998). A second key role for Shh signaling in the OV is to 
promote proximal cell fates (i.e. optic stalk and choroid fissure), and to repress distal cell 
fates (i.e. retina, RPE and lens) (Fig. I-4). The pax2 transcription factor is a critical Shh 
target in this process; pax2 expression in the optic stalk and choroid fissure is dependent 
on Shh (Chiang et al., 1996; Perron et al., 2003; Zhang and Yang, 2001) and Shh 
overexpression is sufficient to induce the expression of pax2 in more distal OV territories 
where it is normally absent (Ekker et al., 1995; Macdonald et al., 1995; Perron et al., 
2003; Zhang and Yang, 2001). pax2 and pax6 repress each other’s transcription and 
thereby form a precise boundary between the optic stalk and retina (Schwarz et al., 2000). 











Modified from Macdonald et al., 1995 
 




as well as in a number of animal model systems, indicating that Shh signaling is critical 
for choroid fissure closure (Macdonald et al., 1997; Otteson et al., 1998; Sanyanusin et 
al., 1995; Schwarz et al., 2000; Torres et al., 1996). 
I. 4. VAX1 AND VAX2 IN THE EYE FORMATION 
Zebrafish provide an excellent model system in which eye development can be 
studied and through which the molecular mechanisms underlying human ocular diseases 
can be elucidated (Goldsmith and Harris, 2003; Gross and Perkins, 2008). Indeed, loss of 
function phenotypes for aussicht, pax2a, vax1/vax2, fgf19, n-cadherin, apc, laminin β1 
and laminin γ1 each lead to colobomas in zebrafish and have been informative in 
furthering our understanding of choroid fissure closure in vivo (Gross and Perkins, 2008; 
Heisenberg et al., 1999; Nakayama et al., 2008). Of particular relevance in this group are 
the vax1 and vax2 genes. The vax genes are co-expressed in the optic stalk and ventral 
optic cup, with vax1 enriched in the optic stalk and vax2 enriched in the ventral optic cup 
(Barbieri et al., 1999; Hallonet et al., 1998; Ohsaki et al., 1999; Take-uchi et al., 2003). 
Similar to pax2, at these early developmental stages vax1/vax2 gene expression is also 
dependent on Shh (Perron et al., 2003; Take-uchi et al., 2003), and Shh overexpression is 
sufficient to increase both vax1 and vax2 levels (Sasagawa et al., 2002; Zhang and Yang, 
2001). Targeted knockout of either vax1 or vax2 leads to ventral optic cup defects and 
colobomas in mouse (Barbieri et al., 2002; Bertuzzi et al., 1999; Hallonet et al., 1999; 
Mui et al., 2002), and similarly, morpholino disruption of vax1 and vax2 results in ventral 
optic cup defects and colobomas in zebrafish (Take-uchi et al., 2003). The vax proteins 
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function in the optic stalk and ventral optic cup by repressing pax6 expression to promote 
proximal OV fates over more distal ones (Mui et al., 2005; Take-uchi et al., 2003). 
Combined, what emerges from these studies is a model in which Shh signaling activates 
pax2 and vax1/vax2 dependent pathways, where the pax2 pathway directly regulates optic 
stalk and choroid fissure formation while the vax1/vax2 pathway represses retina and 
RPE differentiation in the optic stalk and ventral optic cup. 
 
Although defects in choroid fissure closure result in colobomas and incidences of 
colobomas are relatively high within the human population, the molecular mechanisms 
and the cellular processes that facilitate choroid fissure closure have not been well 
characterized in any vertebrate organism. The molecular basis of the defects underlying 
colobomas is largely unknown and there are few experimentally tractable animal models 
for studying their etiology. Here, my studies utilized the zebrafish, Danio rerio, to 
elucidate the mechanisms that underlie ventral retina formation and choroid fissure 
closure. Many disrupted genes and pathways identified as integral to the formation of the 
zebrafish eye produce phenotypes that resemble disorders of the human visual system 
(Gross and Perkins, 2008; Goldsmith and Harris, 2003). Thus, characterization of the 
molecular mechanisms of eye development in zebrafish will shed light on the molecular 







Zebrafish blowout provides genetic evidence for patched1-mediated 
negative regulation of hedgehog signaling within the proximal optic 
vesicle of the vertebrate eye 
 
II. 1. BACKGROUND  
With an interest in better understanding the molecular mechanisms underlying 
OV morphogenesis and choroid fissure closure, I have positionally cloned and 
characterized a recessive zebrafish mutant named blowout (blw), that was originally 
identified in the large-scale mutagenesis screen in Tübingen (Karlstrom et al., 1996). blw 
mutants possess colobomas and defects in retinotectal projections, although visual 
function is relatively normal when tested in optokinetic response assays and by 
electroretinograms (Karlstrom et al., 1996; Neuhauss et al., 1999). Positional cloning of 
blw revealed a nonsense mutation in patched1 (ptc1) as the cause of these ocular defects. 
Loss of ptc1 function leads to an expansion of Hh target gene expression in blw mutants. 
Within the OV, pax2a expression is expanded distally at the expense of pax6 and as a 
result, the optic stalk expands into the ventral optic cup. This appears to physically 
prevent the lateral edges of the choroid fissure from meeting and fusing. Blocking Hh 
pathway activity with cyclopamine suppressed colobomas in blw mutants, indicating that 
constitutive Hh pathway activity is likely the molecular mechanism underlying the 
coloboma phenotype in blw. These observations highlight the critical role that Hedgehog 
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pathway activity plays in mediating patterning of the proximal/distal axis of the optic 
vesicle during the early phases of eye development, and they provide genetic 
confirmation for the integral role that patched1-mediated negative regulation of 
Hedgehog signaling plays during vertebrate eye development.  
 
II. 2. RESULTS 
II. 2. 1. Blowout mutants possess defects in choroid fissure closure   
blw mutants present with obvious colobomas (Fig. II-1A–D). In mutants, the 
choroid fissure has not closed and as a result, retinal and RPE tissue are not contained 
within the eyecup (Fig. II-1E–I). Severity of the phenotype varies between homozygous 
embryos with phenotypes ranging from subtle, unilateral colobomas in some embryos to 
severe, bilateral colobomas in others. Retinal and RPE tissue extend from the eyecup into 
the forebrain in the most severely affected mutants (Fig. II-1I), while in those less 
severely affected, a cleft is observed surrounding the choroid fissure but little to no 
retinal tissue has expelled through this cleft (Fig. II-1H). Penetrance of the phenotype 
also varies between clutches, ranging from 3% – 22% of total embryos in any given 
clutch derived from heterozygous parents developing a coloboma. Within the eye, 
beyond these containment defects, other aspects of development and patterning appear 
normal. Lens and RPE formation are unaffected, retinal lamination is normal and all 
retinal cell types are present in mutant embryos (Figure II-2 and data not shown). Retinal 













Figure II-1. blowout mutants present with colobomas. 
Wild-type (A,C) and blw (B,D) mutant embryos at 50hpf (A,B) and 5dpf (C,D) imaged 
laterally (A,B) and ventrally (C,D). Colobomas can be unilateral or bilateral, and these 
blw mutants show bilateral incidence. Arrows in A,B point to the choroid fissure. Retinal 
tissue expelled from each eye has been outlined to illustrate the extent of the coloboma in 
C,D. Transverese histological sectioning of wild-type (E,G) and blw (F,H,I) eyes. 
Colobomas are obvious at 3dpf in blw (F); however, at later time points their severity 
varies ranging from mild (H) to severe (I). Lens and retinal development appear normal 















Figure II-2. Retinal development is largely normal in blowout. 
Immunohistochemical analysis of retinal ganglion cells (RGCs) via zn8 staining (A,D), 
rod photoreceptors via zpr3 staining (B,E) and red/green double cones via zpr1 staining 
(C,F) in transverse retinal cryosections. All retinal cell types are present and are properly 
distributed in blw mutants, and retinal cell numbers are also similar between wild-type 
and blw mutant eyes. RGC organization is affected in blw mutants where RGC axons do 
not assemble into a tight bundle as they exit the eye (arrow in D). Photoreceptor outer 
segments are present in the retinal territories that are not contained within the eye cup 
(arrows in E,F). Antibody stains are red and nuclei are counterstained green with Sytox 





split into two or more tracts that exit the eye through the colobomatous choroid fissure 
opening (Fig. II-2D). Indeed, retinotectal pathfinding defects have been previously 
described for this mutant and these may result from this inability to assemble the axons 
into a tight bundle as they exit the eye (Karlstrom et al., 1996). Interestingly, the region 
of the retina that extends from the eyecup and into the forebrain develops photoreceptors 
with fairly normal outer segment morphology as demonstrated by immunostaining for 
rhodopsin (Fig. II-2E) and red/green cone opsin (Fig. II-2F), indicating that apposition to 
the RPE is not necessary for outer segment morphogenesis.  
II. 2. 2. Colobomas in blowout are not likely a result of retinal overproliferation or 
an absence of Bruch’s membrane  
 
Overproliferation within the retinal neuroepithelium has been shown to lead to 
colobomas (Kim et al., 2007) and thus, I first tested the hypothesis that retinal cells 
overproliferated in blw leading to a rupture of the optic cup, and an expulsion of retinal 
tissue into the forebrain. Proliferation was assessed using BrdU incorporation assays, and 
BrdU exposures were performed spanning several time points of development (e.g. 24–
36hpf, 42–48hpf and 72–96hpf; Fig. II-3A,B and data not shown). BrdU incorporates 
into DNA during S-phase and serves as a useful readout of cell proliferation over a given 
time period. Quantification of the number of BrdU positive cells over these exposure 
periods revealed that they were present in similar numbers and location to those in wild-
type siblings (Fig. II-3C and data not shown) indicating that that overproliferation of the 







Figure II-3. Retinal cell proliferation and Bruch’s membrane formation are both 
normal in blowout. 
(A,B) Wild-type (A) and blw (B) embryos were exposed to BrdU from 42hpf to 48hpf 
and immediately sacrificed. BrdU positive cells (red) are observed throughout the retinas 
of wild-type and blw mutant embryos in similar proportions (C; no statistical difference - 
Fisher’s exact test). Additional exposure periods (24–36hpf, 72–96hpf) resulted in 
identical regions of proliferation in the retinas of wild-type and blw mutants (data not 
shown). (D,E) Bruch’s membrane, a basement membrane at the posterior of the eye, 
highly expresses the laminin-111 protein (Lee et al., 2007). Shown here are images of 
12um cryosections from wild-type (D) and blw (E) whole-mount embryos stained for 
laminin-111 protein at 48hpf. Laminin-111 levels and distribution are similar between 
wild-type and blw embryos. The optic stalk appears abnormal in blw, as it remains 
connected to the retina at 48hpf (arrows in B,E), while in wild-type siblings it has 
degenerated. Transverse sections, dorsal is up in all images. 
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Basement membrane abnormalities are also known to contribute to colobomas 
(Gross et al., 2005; Hero et al., 1991; Lee and Gross, 2007), so I next tested the 
hypothesis that basement membrane defects might underlie the colobomas in blw. 
Bruch’s membrane is a retinal basement membrane that separates the RPE from the 
choriocapillaris at the posterior of the eye and thus provides a physical barrier containing 
the retina and RPE within the optic cup. Laminin-111 protein is highly expressed in 
Bruch’s membrane (Lee and Gross, 2007), so I utilized an antibody against laminin-111 
to determine if Bruch’s membrane was present in blw mutants. At all time points 
examined, laminin-111 levels in blw were comparable to those in wild-type embryos 
(Fig. II-3D,E). While this observation suggests that Bruch’s membrane is unaffected in 
the mutants, laminin-111 is not expressed in the colobomatous area because the retina 
and RPE are expelled through this region. Therefore, while Bruch’s membrane appears 
normal in blw mutants, I cannot rule out the possibility that there might be lower laminin-
111 levels in the region of the choroid fissure and that these reduced levels compromise 
retinal containment and contribute to the colobomas in blw. Additional histological and 
molecular evidence described below makes this an unlikely scenario, however. 
II. 2. 3. Optic stalk formation is abnormal in blowout 
In examining DIC images from blw mutant retinal cryosections and laminin-111 
expression in blw, I observed maintenance of the optic stalk in blw mutants relative to 
wild-type embryos in which the optic stalk had degenerated by this time (arrows in Fig.  
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II-3B,E). This prompted us to examine abnormalities in optic stalk formation as a 
potential cause of the colobomas in blw. When one closely examines embryos derived 
from blw heterozygous incrosses at very early stages of development (~20–24hpf), a 
thicker and expanded optic stalk is observed in a subset of these embryos, suggesting that 
optic stalk defects might underlie colobomas in blw mutants (data not shown). To directly 
analyze optic stalk formation in blw I performed serial histological sectioning on several 
mutants and their wild-type siblings at 31hpf (Fig. II-4). By examining serial sections 
taken at the same plane in both wild-type and blw mutants, the optic stalk appeared to be 
larger in the mutants than that in wild-type siblings (Fig. II-4B). Moreover, the optic stalk 
was kinked, and stalk tissue was ectopically located within the choroid fissure, appearing 
to physically prevent the fusion between its lateral edges (arrow in Fig. II-4B). 
I wanted to further examine the optic stalk phenotype in blw to determine if optic 
stalk defects also manifest molecularly with an expansion of the proximal OV marker 
pax2a and a contraction of the distal OV marker pax6, which would suggest shifts in cell 
fate boundaries within the OV from retina to optic stalk. pax2a expression is normally 
limited to the region of the OV fated to become optic stalk as early as 15hpf (Fig. II-5A) 
and by 18hpf, as the OV has fully evaginated from the diencephalon, pax2a expression 
clearly demarcates the optic stalk territory of the OV from the remainder of the OV (Fig. 
II-5B). In blw mutants, the pax2a expression domain has expanded more distally into the 
remainder of the OV (Fig. II-5D,E) suggesting that proximal OV fates are expanded at 
the expense of distal ones. Indeed, the pax6 expression domain is contracted in blw 
















Figure II-4. Optic stalk morphology is abnormal in blowout. 
Single 1.25um oblique histological sections taken from 31hpf wild-type (A) and blw (B) 
embryos taken at the same plane of sectioning. The optic stalk in blw is larger and kinked 
at the distal end (arrow in B). Optic stalk tissue is present at the choroid fissure and 






Figure II-5. The proximal/distal axis of the optic vesicle is disrupted in blowout. 
pax2a marks the proximal OV (optic stalk) in wild-type embryos at 15hpf (A), 18hpf (B), 
24hpf (G) and 36hpf (H), while it is absent at 48hpf (I) owing to the degeneration of the 
stalk by this time. Expression in blw mutants is observed in a broader domain within the 
optic stalk region as early as 15hpf (B) and this expansion is maintained at 18hpf (E), 
24hpf (J) and 36hpf (K, arrow). Expression is not extinguished at 48hpf and can be 
observed to extend into the retina (L, arrow). Conversely, pax6 marks the distal optic 
vesicle (retina and RPE) at 18hpf (C), and expression is substantially contracted within 
distal optic vesicle of blw mutants (F) in a pattern complementary to the expanded 
domain of pax2a. 
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observation strongly suggests that proximal/distal patterning of the OV is disrupted in 
blw mutants during the early phases of eye development. 
pax2a also serves as a useful marker of the optic stalk at 24hpf (Fig. II-5G) and 
36hpf (Fig. II-5H). In blw mutants, the pax2a expression domain has substantially 
expanded and now extends into the retina (Fig. II-5J,K). Moreover, while pax2a 
expression is nearly absent from the wild-type eye at 48hpf, concomitant with optic stalk 
differentiation (Fig. II-5I), in blw mutants expression is not only maintained but it also 
appears to spread into the retina (Fig. II-5L). Interestingly, in some embryos I noted 
asymmetric changes in pax2a expression where one optic stalk would show a large 
increase and the other would show either a more moderate increase or no change from 
wild-type levels (data not shown). As stated above, in some blw mutants, colobomas are 
unilateral while in others they are bilateral and thus, it appears that this asymmetry 
manifests at the molecular level as well as the morphological. 
II. 2. 4. Positional cloning of blowout 
To enable a molecular characterization of blw and its optic stalk phenotypes, I 
next set out to positionally clone the gene and identify the responsible mutation. Linkage 
mapping with microsatellite markers placed the mutation on chromosome 2, between 
Z11410 and Z13521. High-resolution mapping was then performed using additional 
microsatellite markers to refine the blw locus. Using markers z8451 and CH211-261P7-




Figure II-6. Positional cloning of the blowout mutation. 
(A) Genetic map of Chromosome 2 containing the blw mutation. Microsatellite markers 
and BACs are indicated with the number of recombinants and embryos genotyped. (B) 
Sequence chromatogram showing the atp6v0b mutation in blw. DNA sequence from 
wild-type (left) and homozygous (right) blw mutants are shown and the affected base is 
marked by an arrow. Amino acid sequence is listed below the DNA sequence. (C). 
Asn113, changed to Lys in blw (red), is conserved in vertebrate atp6v0b proteins. (D) 
Sequence chromatogram showing the ptc1 mutation in blw. DNA sequence from 
heterozygous (left) and homozygous (right) blw mutants are shown and the affected base 
is marked by an arrow. (E) Schematic of the patched1 protein and the approximate 
position of the stop codon in blw situated after the 8
th
 transmembrane domain. 
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blw locus (Fig. II-6A). Assembly of BACs spanning this region identified ten genes and 
one pseudogene within it (Fig. II-6A and data not shown). cDNAs representing six of 
these genes were cloned and sequenced and, interestingly, separate mutations in two 
different genes were identified in all 526 blw mutant embryos. 
The first mutation identified was a missense mutation in atp6v0b (NM_199561) 
that changed bp520 from T-to-A, resulting in a nonconservative Asn to Lys change at 
position 113 of the protein (Fig. II-6B; www.ensembl.org/Danio_rerio). atp6v0b encodes 
a 22kDa proteolipid subunit (v0c”) of the vacuolar ATPase complex (v-ATPase). The v-
ATPase is a multi-protein complex consisting of thirteen different subunit types that are 
assembled stoichiometrically into a multimeric protein complex (Nishi and Forgac, 
2002). v-ATPases are best known for their roles in H
+
 transport through which they are 
important for intracellular and extracellular acidification events, protein transport and 
membrane fusion (Nelson and Harvey, 1999; Nishi and Forgac, 2002). Additionally, 
several recent studies have identified v-ATPase complex-independent functions for 
individual v-ATPase subunits (Hiesinger et al., 2005; Kontani et al., 2005), and perhaps 
the most interesting of these is in C. elegans where v0 subunits have been shown to be 
involved in mediating the release of Hedgehog-like ligands (Liegeois et al., 2006). The 
v0c” protein is highly conserved in eukaryotes and prokaryotes and Asn113 is also 
conserved in vertebrate v0c” proteins, suggesting that it may be important for protein 
function (Fig. II-6C). The second mutation I identified in blw was a nonsense mutation in 
patched1 (ptc1; NM_130988) that changes bp3119 from G-to-A, resulting in a premature 
stop codon at position 1040 of the Patched1 protein (Fig. II-6D; 
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http://www.ncbi.nlm.nih.gov/entrez). This truncates Patched1 just after the 8
th
 
transmembrane helix (Fig. II-6E). Patched1 is a receptor for Hh ligands and in the 
unoccupied state, it serves as a negative regulator of Hh signaling by inhibiting the 
Smoothened protein. Upon binding of a Hh ligand by Patched, inhibition of Smoothened 
is relieved and a Hh dependent intracellular signaling pathway begins. Two patched 
genes are found in zebrafish, ptc1 and ptc2 (Concordet et al., 1996; Lewis et al., 1999), 
and ptc1 is strongly expressed in the optic stalk during the stages of OV morphogenesis 
(Lewis et al., 1999). Ocular defects have not been described in ptc1 morphants (Beales et 
al., 2007; Wolff et al., 2003), and OV morphogenesis does not appear to be disrupted in 
the zebrafish ptc2 mutant, leprechaun (Koudijs et al., 2005). 
II. 2. 5. Loss of patched1 function is responsible for the blowout phenotype 
ptc1 is expressed in the zebrafish optic stalk (Fig. II-9A,C) (Lewis et al., 1999), 
and gene expression therein is known to be dependent on Hh signaling (Macdonald et al., 
1995; Take-uchi et al., 2003) making ptc1 a likely candidate for underlying the blowout 
phenotype. Indeed, that I observe Hh overexpression-like phenotypes in blw (e.g. 
expansion of pax2a expression at the expense of pax6 expression) supports the 
hypothesis that loss of ptc1 function may underlie these phenotypes. To determine if loss 
of ptc1 function leads to colobomas, I injected a translation blocking MO targeting the 
ptc1 transcript into 1-cell embryos (after Wolff et al., 2003). Knock-down of ptc1 
translation resulted in severe colobomas in all injected embryos, as well as additional  
 24 
 
Figure II-7. Loss of ptc1 leads to colobomas and ventral optic cup defects. 
1.3ng injection of a translation blocking morpholino targeting ptc1 transcripts (ptc1MO) 
results in colobomas. Lateral views of a (A) Control morpholino (ControlMO) injected 
and (B) ptc1 morphant at 2.5dpf. Morphants possess bilateral colobomas (arrow in B). 
Morphants are more severely affected than blw mutants, showing medial displacement 
and lateral flexure of the eyes, and lens displacement. Overt brain and muscle defects are 
also observed. (C–E) Transverse histological sections from a 5dpf wild-type (C) and ptc1 
morphants (D,E). Severe colobomas are obvious in the morphants (arrows in D,E), and in 
the many of them the lens is also displaced and lies out of the plane of the section. pax2a 
expression is expanded into the retina at 24hpf (F,G) and pax6 expression is contracted 
(H,I). The Hh target genes ptc1 (J,K) and ptc2 (L,M) also show expanded domains of 
expression in ptc1 morphants.  
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overt phenotypes in the eye, brain and muscles (Fig. II-7A,B and data not shown). 
Histological analysis of ptc1 morphants confirmed the degree to which the eye is affected 
in these embryos (Fig. II-7C–E). Colobomas in ptc1 morphants were often more severe 
than those observed in blw and the eyes of ptc1 morphants are rotated laterally relative to 
wild-type embryos, and their overall position is displaced medially, likely owing to the 
substantial coloboma and ventral retina defects. Many ptc1 mutants also showed small, 
displaced lenses, a phenotype that does not appear in blw mutants. The lens phenotype in 
ptc1 morphants is identical however to that reported to occur as a result of Shh 
overexpression where lens tissue is substantially reduced or absent (Barth and Wilson, 
1995; Dutta et al., 2005; Yamamoto et al., 2004). Unfortunately, rescue experiments via 
injection of full-length ptc1 mRNA into blw mutants and/or ptc1 morphants were not 
successful, possibly owing to the large size of the ptc1 transcript and/or degradation of 
the mRNA once injected (data not shown). Thus, the biological relevance of the 
increased severity of the ptc1 morphant phenotype remains uncertain. However, and of 
particular note, molecular changes in ptc1 morphants are identical to those observed in 
blw mutants where pax2a expression is expanded and extends into the retina (Fig. II-
7F,G) and pax6 expression is contracted (Fig. II-7H,I). These results support the 
hypothesis that loss of ptc1 function is very likely to be the underlying cause of the 
colobomas in blw. 
I also wanted to determine if atp6v0b
N113K
 was causative or if it contributed to the 
colobomas observed in blw. As mentioned above, v0 subunits have been shown to be 
involved in mediating the release of Hedgehog-like ligands in C. elegans (Liegeois et al., 
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2006). Changes in pax2a and pax6 expression are hallmark molecular readouts of Hh 
overexpression phenotypes in the eye and that I observe such changes in blw (Fig. II-5) 
made it possible to envision a scenario whereby the atp6v0b
N113K
 mutation could underlie 
or contribute to these ocular defects. 
Five recessive mutations in different v-ATPase complex subunits have been 
identified in zebrafish, as well as a mutation in a v-ATPase associated protein 
(Amsterdam et al., 2004) and we have previously demonstrated that v-ATPase function is 
required for normal eye development (Gross et al., 2005). These v-ATPase roles, 
however are largely in regulating RPE pigmentation, in mediating RPE/photoreceptor 
interactions and in regulating cell survival in the ciliary marginal zones of the retina 
(Nuckels et al., 2009). Importantly, each of these v-ATPase mutations is a null or severe 
loss of function allele, and in none of these mutants are colobomas ever observed. Thus, I 
hypothesized that atp6v0b
N113K
 was not likely to be a loss of function mutation, and I 
tested this hypothesis by MO interference. As expected, MO knockdown of atp6v0b does 
not lead to colobomas, and atp6v0b morphants do not resemble blw mutants (Fig. II-8), 
rather, they resemble other v-ATPase loss of function mutants (Gross et al., 2005). 
Additionally, neither injection of atp6v0b mRNA or a BAC containing the atp6v0b locus 
into embryos derived from heterozygous blw incrosses was able to rescue the blw 
phenotype in these embryos (data not shown). Thus, I conclude that atp6v0b
N113K
 is not a 
loss of function allele. 
I also wanted to determine if the atp6v0b
N113K
 mutation might possibly be a gain 















Figure II-8. atp6v0b morpholinos do not phenocopy blowout. 
(A) The atp6v0b predicted genomic organization. atp6v0b MO targets the exon1/intron1 
splice junction and leads to the inclusion of a 705bp intron1 and the introduction of a 
premature stop codon. (B) RT-PCR validation of splice blocking efficacy of the atp6v0b 
MO. (C) Control injected and (D) atp6v0b morphant (13ng) at 5dpf. Morphants display 
oculocutaneous albinism and retinal degeneration but show no signs of colobomas even 




wild-type atp6v0b or atp6v0b
N113K
 into wild-type 1-cell stage embryos and I assayed 
overall eye development and choroid fissure closure through 5dpf. While defects in eye 
development were observed that included unilateral microphthalmia, mild to severe 
cyclopia and a small percentage of colobomas, their incidence was not significantly 
higher in atp6v0b
N113K
 injected embryos than those injected with wild-type atp6v0b 
mRNA (data not shown). Thus, while I cannot definitively rule out the hypothesis that 
the atp6v0b
N113K
 mutation contributes to the colobomas in blw, possibly acting as a 
modifier locus, neither the results of MO loss of function, mRNA and BAC rescue 
assays, nor those testing for gain of function by mRNA overexpression provide 
compelling support for this hypothesis. 
II. 2. 6. The expression of Hedgehog targets is expanded in blowout  
Truncation of Patched1 after the 8
th
 transmembrane helix likely prevents it from 
inhibiting Smoothened, leading to an expansion of Hh target gene expression in blw 
mutants. This model is consistent with published reports demonstrating that Hh 
overexpression alters gene expression in the optic stalk and optic cup in zebrafish (Ekker 
et al., 1995), and consistent with our observations that expression domain of the Shh 
target pax2a, is expanded in blw mutants and ptc1 morphants, while the pax6 domain is 
contracted (Fig. II-5, Fig. II-7). ptc1 and ptc2 are also targets of Hh pathway activation 
(Lewis et al., 1999, Concordet et al., 1996), likely acting in a negative feedback 
mechanism to limit the diffusion of the Hh morphogen and thus, limit the range of Hh 







Figure II-9. The domains of the Hh target genes ptc1 and ptc2 are expanded in 
blowout. 
Expression of ptc1 in the optic stalk of wild-type embryos at 24hpf (A) and 30hpf (C). 
(B,D) Expression in blw mutants is expanded and appears more intense at these time 
points both in the optic stalk, as well as in the brain and musculature (not shown). ptc2 
expression is also expanded in blw mutants (F) relative to wild-type siblings (E). 
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is altered in blw, I assayed their distributions by in situ hybridization (Fig. II-9). In wild-
type embryos, ptc1 is strongly expressed in the optic stalk at 24 and 30hpf (Fig. II-9A,C), 
as well as throughout the ventral brain and the somites (Concordet et al., 1996 and data 
not shown). In blw mutants, ptc1 expression appears to be expanded and the message is 
distributed in a substantially broader domain of expression (Fig. II-9B,D). Expanded 
domains of expression were also observed in the ventral brain and the somites (data not 
shown). Similarly, expansion of ptc1 expression was also observed in ptc1 morphants 
(Fig. II-7J,K). Examination of ptc2 expression in blw mutants yielded similar results (Fig. 
II-9E,F), although changes in ptc2 distribution were variable in blw mutants with only a 
subset (~40%) showing grossly obvious changes. ptc2 expression was substantially 
altered in all ptc1 morphant embryos (Fig. II-7L,M). I highlight that while in situ 
hybridizations are not quantitative assays, that the ptc1 and ptc2 in situ signals appear to 
be more intense and expanded in the brain and somites in both blw mutant and ptc1 
morphant embryos strongly suggests that Hh pathway activity is upregulated as a result 
of loss of Patched1 function.  
II. 2. 7. Homozygous blowout mutants are viable and reveal post-metamorphic roles 
for Patched1 function in the adult zebrafish 
I was able to rear ~2–3% of homozygous blw mutant embryos to adulthood and 
the resulting fish displayed a number of obvious morphological defects (Fig. II-10). blw 
homozygotes were generally smaller in size than their heterozygous and wild-type 









Figure II-10. blowout homozygous adult fish. 
(A,B) blw heterozygous adult fish do not show detectable phenotypes. (C,D) blw 






was normal in the homozygous mutant fish. Embryos derived from homozygous mothers 
continued to show variable rates of phenotypic penetrance, never reaching predicted 
Mendelian ratios. On average, the incidence of colobomas was approximately 35% when 
a homozygous female was mated with a heterozygous male, and incidences rose to over 
80% when a homozygous female was mated to a homozygous male. In nearly all mutants 
derived from homozygous mothers that displayed colobomas, these were almost always 
observed bilaterally. Importantly, beyond this difference, blw mutants derived from 
homozygous mothers did not show markedly more severe or more widespread 
developmental defects than those derived from heterozygous mothers, indicating that 
there is not likely to be a significant maternal mRNA or protein rescue of the blw 
phenotype that masks defects in embryos derived from heterozygous carriers. 
II. 2. 8. Is upregulation of Hh pathway activity the mechanism that leads to 
colobomas in blowout? 
Given the similarities between Hh overexpression and the blw mutation (e.g. 
changes to pax2a, pax6, ptc1 and ptc2 expression), I next sought to directly test the 
hypothesis that upregulation of Hh pathway activity is the molecular mechanism 
underlying colobomas in blw. To test this hypothesis I utilized cyclopamine, a 
pharmacological inhibitor of the Hh pathway that acts downstream of Patched (Cooper et 
al., 1998; Taipale et al., 2002), and asked whether low doses of cyclopamine were 
capable of suppressing colobomas in blw mutants. Indeed, a similar rescue paradigm has 









Figure II-11. Cyclopamine suppression of colobomas in blowout. 
(A) On average, 89.8% of vehicle (EtOH) treated embryos derived from homozygous 
incrosses displayed colobomas, while exposure of siblings to 2uM or 3uM cyclopamine 
from 5.5hpf to 24hpf suppressed colobomas to 26.7% and 16.7%, respectively (*** p < 
0.0001, Fisher’s exact test). (B) Treatment of embryos derived from homozygous 
incrosses to vehicle (EtOH), or 3uM cyclopamine from 5.5hpf to 13hpf, or 13hpf to 
24hpf was also able to suppress colobomas from an average of 82% in vehicle controls to 
4% in 5.5–13hpf treated embryos (*** p < 0.0001, Fisher’s exact test), and to 65.3% in 




pathway (e.g. lep/ptc2 and uki/Hip; (Koudijs et al., 2005). For these assays, I took 
advantage of homozygous viable blw adults to increase the incidence of coloboma 
phenotypes and to abrogate the need to genotype each rescued embryo as I knew a priori 
that all were homozygous mutants. Low levels of cyclopamine (≤ 3uM) did not lead to 
noticeable defects in eye development (data not shown) and thus, I assayed whether these 
subthreshold levels were able to suppress colobomas in blw. Exposure of blw mutants to 
2uM or 3uM of cyclopamine between 5.5hpf and 24hpf was highly effective in 
suppressing the incidence of colobomas (Figure II-11A). In vehicle treated sibling 
controls, 89.8% displayed colobomas while 2uM cyclopamine suppressed this to 26.7% 
and 3uM cyclopamine to 16.7% (p < 0.0001; Fisher’s exact test). 
I next sought to determine if I could identify a window of time between 5.5hpf 
and 24hpf during which maximal rescue of colobomas in blw mutants could be achieved, 
thereby indicating the window of time when Hh signaling is likely to be required for 
proximal/distal patterning of the OV during normal embryogenesis. Given that 3uM 
cyclopamine was able to significantly rescue colobomas in blw mutants (Fig. II-11A), I 
utilized this concentration and exposed embryos over two time windows: 5.5hpf – 13hpf 
and 13hpf – 24hpf (Fig. II-11B). Maximal rescue was achieved by cyclopamine exposure 
during the early 5.5hpf – 13hpf window with incidences of colobomas dropping from 
82% to 4% (p < 0.0001; Fisher’s exact test). Cyclopamine exposure from 13hpf – 24 hpf 
resulted in 65.3% of embryos displaying colobomas (p = 0.0278; Fisher’s exact test). 
While the rescue from 13hpf – 24 hpf cyclopamine exposure 
 35 
is statistically significant when compared to vehicle treated controls, it is substantially 
lower than that achieved during the early 5.5hpf – 13hpf window of treatment suggesting 
that it is during this early time window that the Hh signal is normally conveyed to the OV 
to segregate it into the appropriate proximal and distal territories. 
 
II. 3. DISCUSSION  
II. 3. 1. Blowout is a loss of function mutation in Patched1 
In this study I have characterized zebrafish blw, a recessive mutation that presents 
with ocular coloboma and defects in retinotectal axon pathfinding (Karlstrom et al., 
1996). Positional cloning of blw identified two mutations; the first of these affects ptc1, 
resulting in a stop codon that truncates the Patched1 protein after the 8
th
 transmembrane 
domain, and the second affects atp6v0b, changing a conserved asparagine residue to a 
lysine. MO targeting of ptc1 transcripts results in colobomas while MO targeting of 
atp6v0b transcripts did not lead to colobomas; rather, loss of atp6v0b function resulted in 
oculocutaneous albinism and retinal degeneration. These phenotypes were identical to 
those observed in six other loss of function mutations in v-ATPase components or v-
ATPase associated proteins, suggesting that the atp6v0b
N113K
 mutation was not a loss of 
function allele (Gross et al., 2005; Nuckels et al., 2009). Indeed, neither atp6v0b mRNA 
or BAC injections were able to rescue or alter the ocular defects in blw mutants. 
Additionally, overexpression of atp6v0b
N113K
 mRNA did not lead to ocular defects at a 
higher level than that resulting from overexpression of wild-type atp6v0b mRNA, also 
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suggesting that the atp6v0b
N113K
 mutation was not a neomorphic or gain of function 
allele. Thus, while I cannot exclude the possibility that atp6v0b
N113K
 acts as a modifier of 
ptc1
W1040X
, our results support a model in which the coloboma phenotypes in blw stem 
solely from a loss of Patched1 function. 
Interestingly, ptc1 morphants showed more severe ocular phenotypes than those 
observed in blw mutants. I was able to rear homozygous mutants to adulthood and 
embryos derived from incrosses between homozygous parents did not display more 
severe ocular phenotypes than those derived from heterozygous parents. This indicates 
that there is not a maternal supply of mRNA or protein that partially rescues the ocular 
phenotypes in blw mutants derived from heterozygous mothers. Phenotypic penetrance 
varies in clutches of embryos derived from heterozygous parents and while the 
phenotypic penetrance was higher in clutches derived from homozygous parents, they 
still never reached predicted ratios. These observations in conjunction with the more 
severe ocular phenotypes present in ptc1 morphants, suggest that the ptc
W1040X
 mutation 
may be a hypomorphic partial loss of function ptc1 allele. 
While direct biochemical analysis of the truncated Ptc1
W1040X
 protein will be 
required to test this hypothesis, should it retain some of its ability to repress Smoothened, 
it would be interesting with respect to other mutations that have been identified in the C-
terminus of the Patched1 protein. For example, two missense mutations in the human 
PATCHED1 (PTCH) gene have been identified that alter the C-terminal domain of PTCH 





 transmembrane domains of PTCH (PTCH
T728M
) and the second resides in 
 37 




 transmembrane domains of PTCH 
(PTCH
T1052M
). Patients with these mutations display holoprosencephaly and other 
developmental defects, but they do not display colobomas. Interestingly, their phenotypes 
more closely resemble loss of function mutations in SONIC HEDGEHOG (SHH) than 
loss of function mutations in PTCH. The biochemical nature of these human mutations 
have not yet been characterized but given the similarity in phenotypes between them and 
SHH mutations, it may be that they disrupt the portion of the protein that is required for 





 may act as a dominant negative such that even in the presence of SHH, these 
mutated proteins still represses SMOOTHENED activity and keep the Hh pathway 
inactive. 





 intracellular loops, behaves quite differently than these point 
mutations. In blw/ptc1 mutants, the Shh pathway appears to be constitutively active 
although with variable penetrance and relatively milder phenotypes when compared to 
those that arise from Shh overexpression (Ekker et al., 1995). It is possible that the 




 transmembrane domains still retains 
some of its repressive ability to block Smoothened function when Hh signals are present 
and thus it is able to ameliorate some of the phenotypes that would be expected to arise if 
the Hh pathway was fully activated (i.e. to resemble Shh overexpression phenotypes). It 
is also possible that there are other redundant negative regulators of the Hh pathway that 
prevent full activation of the pathway in blw/ptc1 mutants, which thereby influence the 
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penetrance of the phenotype. Ptc2 is an ideal candidate to possess a redundant function 
and indeed, a recent report by Koudijs et al. (2008) demonstrates that the ocular 
phenotypes in ptc1/ptc2 double mutants are much more similar to Shh overexpression 
phenotypes than those present in the single mutants. 
II. 3. 2. Ptc1-dependent regulation of Hh signaling is required for formation of the 
optic stalk-retina interface  
Shh signaling is a key regulator of proximal OV cell fates (Amato et al., 2004). 
pax2a, a Shh target, has been shown to directly regulate optic stalk and choroid fissure 
formation in the proximal OV, while pax6 encodes a key regulatory factor involved in the 
specification of retina and RPE cell fates within the distal OV (Chow and Lang, 2001; 
Adler and Canto-Soler, 2007). In the blw mutant OV, the early domain of pax2a 
expression is expanded distally and pax6 expression is contracted (Fig. II-5). These 
results support a model in which proximal OV cell fates are expanded in blw mutants at 
the expense of distal ones, and this leads to an enlargement of the optic stalk. Indeed, 
these changes in gene expression in blw are identical to those observed from Shh 
overexpression in zebrafish, Xenopus and chick (Ekker et al., 1995; Macdonald et al., 
1995; Perron et al., 2003; Sasagawa et al., 2002; Zhang and Yang, 2001). One problem 
with this model however, is that despite the optic stalk expansion and coloboma 
phenotypes, later aspects of distal OV (i.e. retinal) formation are normal in blw mutants. 
One would expect that if early distal OV patterning were compromised, later retinal and 
RPE fates would necessarily be affected. This is not the case in blw mutants; retinal 
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patterning is unaffected and overall retina size is similar to that in wild-type siblings. 
While I do not yet know how distal fates recover in blw, one possible mechanism is that 
the remaining pax6 expressing distal OV is able to utilize pax6 in a non-cell autonomous 
fashion (e.g. Lesaffre et al., 2007), and thereby counteract the effects of the expanded 
proximal pax2a expressing regions. In this scenario, the optic stalk would be refractory to 
this “rescue” and thus still expand into the choroid fissure, but the remainder of the distal 
OV is able to develop relatively normally. Additional analyses are required to test this 
hypothesis and to determine why blw mutants do not display distal OV defects despite the 
early changes in gene expression domains observed within the OV at 18hpf. 
Colobomas in blw were suppressed by pharmacological inhibition of Hh pathway 
activity indicating that it is dysregulation of this pathway that underlies the coloboma 
phenotype. I suspect that colobomas result from the expansion of the optic stalk into the 
choroid fissure which prevents its lateral edges from meeting and fusing, however it is 
also possible that overproliferation of cells within the optic stalk itself contributes to 
these colobomas by further expanding the optic stalk into the ventral optic cup, and thus 
impeding its closure. Hh signaling is known to regulate cell proliferation in a number of 
cellular and developmental contexts, including the eye, through the activation of key cell 
cycle regulators like cyclin D1, cyclin B1 and cyclin A2, as well as the phosphatase, 
Cdc25, that collectively function to maintain proliferative cells in the cell cycle (Adolphe 
et al., 2006; Agathocleous et al., 2007; Locker et al., 2006). In blw, a Hh dependent 
dysregulation of cell proliferation may also be occurring within the proximal OV which 
increases the amount of stalk tissue and thereby physically impedes closure of the 
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choroid fissure. It will be interesting in future studies to determine if proliferation and the 
expression of these cell cycle components are upregulated in the optic stalk of blw 
mutants. 
Hh signaling is required for later aspects of optic stalk development in mouse 
whereby retinal ganglion cell derived Shh is required for optic stalk neuroepithelial cells 
to develop into astroglia, as well as to suppress pigment cell formation around the optic 
nerve (Dakubo et al., 2003; Torres et al., 1996). I observed continued expression of 
pax2a mRNA in the optic stalk and ectopically in the retina of blw mutants when 
compared to that in wild-type siblings, where expression had ceased and differentiation 
commenced by 48hpf. Beyond the coloboma induced morphological abnormalities in the 
retina of blw mutants, histologically and immunohistocehmically their retinas appear 
relatively normal. That said, I do not know the effect of the mutation on later aspects of 
optic stalk development, as I have not yet assayed the differentiated state of the optic 
stalk in blw mutants. Based on the results in mouse, one might hypothesize that 
neuroepithelial cells of the blw optic stalk would remain undifferentiated due to the 
prolonged expression of these specification genes. Conversely, one might also 
hypothesize that the optic stalk in blw might differentiate but that glial cells would be 
overrepresented as a result of dysregulated Hh target gene expression. blw was originally 
identified based on defects in retinotectal pathfinding (Karlstrom et al., 1996), and in 
either of the above scenarios, retinal ganglion cell axons would likely not properly find 
their way to the optic nerve and/or the optic tectum. Future studies will be required to 
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examine these possibilities and determine the molecular basis for the pathfinding defects 
in blw. 
Finally, underscoring the importance of Patched dependent regulation of Hh 
signaling in human disease, loss of function mutations in human PTCH lead to Basal Cell 
Naevus or Gorlin syndrome (BCNS; OMIM #109400), a developmental disorder 
characterized by dental, skeletal and ocular defects (Hahn et al., 1996; Johnson et al., 
1996). Ocular phenotypes associated with BCNS include abnormal myelination of the 
optic nerve, retinal dysplasia and colobomas; however, the mechanism through which 
PTCH mutations lead to these ocular defects has not been established (Black et al., 2003; 
De Jong et al., 1985; Manners et al., 1996). Our results demonstrate a critical role for 
zebrafish Patched1 in negatively regulating Hedgehog signaling within the proximal OV 
and possibly in functioning to restrict Hh-dependent cell proliferation therein. BCNS-
related pathologies may result from unrestricted proliferation within the retina, a model 
recently proposed by Black et al. (2003). That a subset of homozygous adult blw mutants 
are viable will enable us to test this hypothesis and to identify later roles for ptc1-
dependent Hh regulation in ocular development and homeostasis, as well as to model 





FUNCTION AND REGULATION OF BCL6 DURING ZEBRAFISH 
EYE DEVELOPMENT  
 
III. 1. INTRODUCTION – BCL6 (B CELL LEUKEMIA/LYMPHOMA 6) PROTEIN 
III. 1.1. Regulation of Bcl6 
The human proto-oncogene BCL6 (B cell leukemia/lymphoma 6) encodes a 
sequence-specific transcriptional repressor (Chang et al., 1996; Seyfert et al., 1996). 
BCL6 was originally studied based on its involvement in certain types of lymphomas, in 
which BCL6 expression is deregulated (Baron et al., 1993; Kerckaert et al., 1993; Ye et 
al., 1993). Chromosomal translocations affecting band 3q27 were found to deregulate 
BCL6 expression by a promoter substitution putting heterologous promoters adjacent to 
the BCL6 coding region (Ohno, 2004; Pasqualucci et al., 2003; Ye et al., 1995). 
Lymphomas with deregulated BCL6 expression were found to contain somatic point 
mutations in the 5’ non-coding region of BLC6 (Migliazza et al., 1995). From the study 
of lymphomas, it appears likely that BCL6 expression is strictly regulated during 
differentiation of B cells. Indeed, BCL6 is not detectable in pre-germinal center B cells, 
but is exclusively expressed in germinal center B cells, and this expression is not 
observed in differentiated plasma B cells (Cattoretti et al., 1995; Flenghi et al., 1995; 
Onizuka et al., 1995). BCL6 is transcriptionally down-regulated by signaling induced by 
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CD40 receptors (Allman et al., 1996). BCL6 also can be regulated at the protein level; 
phosphorylation mediated by MAP kinase targets BCL6 for degradation when antigens 
bind to B cell receptors (Niu et al., 1998).  
III. 1.2. Function of Bcl6 
BCL6 is known to be important for germinal-center formation in mouse (Dent et 
al., 1997). In germinal-center B cells, BCL6 plays an important role in circumventing 
apoptotic responses from DNA breaks for immunoglobulin class switch recombination by 
directly suppressing the expression of p53 tumor suppressor gene (Phan and Dalla-
Favera, 2004). Furthermore, in the olfactory system, BCL6 functions as an anti-apoptotic 
factor providing enough time for olfactory sensory neurons to differentiate into mature 
neurons in mouse (Otaki et al., 2010). While the involvement of BCL6 in B cell 
development and lymphomagenesis has been well studied, its functions during embryonic 
development remain poorly elucidated. Recently, BCL6 has been reported to be involved 
in the patterning of left-right asymmetry by inhibiting Notch target genes, thus 
maintaining the expression of Pitx2 in the left lateral plate mesoderm in Xenopus (Sakano 
et al., 2010).  
BCL6 is known to have three functional domains, including a POZ/BTB
 
domain 
at the N terminus, a central repression domain, and a zinc finger motif at the C
 
terminus 
(Bardwell and Treisman, 1994; Stogios et al., 2005; Zollman et al., 1994). Through the 
POZ/BTB domain BCL6 interacts with several corepressors, including BCL6 corepressor 
(BCOR), SMRT (silencing mediator of retinoic acid and thyroid hormone receptor), and 
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NCOR (nuclear receptor corepressor) to silence genes involved in apoptosis
 
and cell 
cycle arrest (Huynh et al., 2000; Polo et al., 2004). The central repression domain of 
BCL6 is involved in associating with a corepressor, metastasis-associated protein 3 
(MTA3) and a HDAC-containing chromatin remodeling complex, Mi-2/NuRD, in order 
to suppress genes responsible for plasma cell differentiation (Fujita et al., 2004; Polo et 
al., 2004). The six Cys2-His2 zinc finger motif plays a role in recognizing specific DNA 
squences (Kawamata et al., 1994).  
III. 1.3. Cofactors of Bcl6 
III. 1.3.1. Bcor (Bcl6 co-repressor) 
 
BCOR is a corepressor that potentiates transcriptional repression by BCL6 
(Huynh et al., 2000). Different types of mutations in BCOR have been found in patients 
with Oculofaciocardiodental (OFCD; OMIM 300166) syndrome, which is an X-linked 
male lethal condition displaying ocular defects (coloboma), cardiac septal defects, and 
dental anomalies (Gorlin et al., 1996; Hedera and Gorski, 2003; Ng et al., 2004; Schulze 
et al., 1999). Knock-down of BCOR in zebrafish and Xenopus embryos recapitulates the 
human syndrome with developmental disruption of the eye including colobomas and 
defects in the skeleton and central nervous system, suggesting that BCOR plays multiple 
critical roles in the development of different organs (Hilton et al., 2007; Ng et al., 2004). 
BCOR is part of a transcriptional repression complex containing Ring finger protein 2 
(RNF2), an E3 ligase that ubiquitinates histone H2A, which is known to keep chromatin 
in a repressed state (Cao et al., 2005; de Napoles et al., 2004; Jason et al., 2005; Wang et 
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al., 2004). FBXL10/JHDM1B, an F-box protein with a JmjC demethylase domain, also 
belongs to the BCOR complex. It is known to demethylate histone H3K36 demethylation 
(Tsukada et al., 2006), known as a silencing mechanism (Bannister et al., 2005; Rao et 
al., 2005). These studies suggest that BCOR functions to silence genes through a 
combination of epigenetic modifications (Gearhart et al., 2006). The BCOR complex is 
recruited by BCL6 to target genes including p53 and cyclin D2 to potentiate 
transcriptional repression in B cells (Gearheart et al., 2006). BCOR is critically involved 
in the patterning of left-right asymmetry by maintaining the expression of xtPitx2c in the 
left side of Xenopus embryos, similar to BCL6 (Hilton et al., 2007; Sakano et al., 2010), 
indicating that BCOR acts as a corepressor for BCL6 in left-right patterning as well.  
III. 1.3.2. Hdac1 (Histone deacetylase 1) 
  
Acetylation is thought to activate transcription by modifying histones (Sterner and 
Berger, 2000) or by directly regulating activity of transcription factors like E2F and p53 
(Barlev et al., 2001). Furthermore, acetylation of transcriptional repressors, like BCL6, is 
also inhibitory, providing a third mechanism by which acetylation can stimulate 
transcription (Bereshchenko et al., 2002). Bereshchenko et al. demonstrated that HDACs 
play an important role in regulating Bcl6 activity by controlling its acetylation state. 
BCL6 is known to require association with complexes containing HDACs and co-
repressors to function as a transcriptional repressor (Dhordain et al., 1997; Dhordain et 
al., 1998; Wong and Privalsky, 1998). In zebrafish, hdac1 mutation results in colobomas 
(Stadler et al., 2005; Yamaguchi et al., 2005). In hdac1 mutants, retinal cells fail to exit 
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the cell cycle and don’t differentiate into neurons and glial cells, suggesting that Hdac1 
promotes cell cycle exit and differentiation of retinal cells. In retinal cell culture, 
inhibition of Hdac function by trichostatin A (TSA) induces expression of Apaf-1, a pro-
apoptotic protein, by increasing expression of upstream regulators like p53, suggesting 
that Hdac activity is involved in regulating apoptosis in the retina (Wallace and Cotter, 
2009; Wallace et al., 2006). 
 
Here, I propose that Bcl6 plays a critical role in preventing apoptosis in the retina 
during eye development, and that this function is required to contain the retina and RPE 
within the optic cup. In addition, I suggest that Vax1 and Vax2 act upstream of bcl6 in 
the ventral retina, and Bcl6 functions along with Bcor and Hdac1 to mediate cell survival 
by regulating p53 within the developing zebrafish retina. 
 
III. 2. RESULTS 
III. 2. 1. bcl6 is expressed in the ventral retina. 
To investigate when and where bcl6 is expressed during zebrafish eye 
development, I examined the expression pattern of bcl6 mRNA by in situ hybridization 
with bcl6 anti-sense ribo-probe at several different time points on wild type embryos. 
bcl6 was expressed in the lens and myotome prior to 24 hpf and disappeared after 24 hpf 
(data not shown). In the retina, bcl6 started to be expressed in the choroid fissure at 30 
hpf, and this expression domain began to expand into the nasal retina at 39 hpf (Figs. III-
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1A-C). Transcripts expanded both nasally and temporally in the outermost region of the 
retina by 48 hpf and eventually bcl6 was detected in most of the ventral retina at 54 hpf 
(Figs. III-1D-F). bcl6 is also detected in the optic tectum after 39 hpf (Figs. III-1G,H). 
III. 2. 2. Vax1 and Vax2 regulate the expression of bcl6 in the ventral retina. 
It has been reported that Vax1 and Vax2 are expressed in the optic stalk and 
ventral retina during early eye development when they regulate transcription of target 
genes involved in eye development. Moreover, loss of Vax1 and Vax2 function results in 
colobomas in mouse and zebrafish (Take-uchi et al., 2003). To investigate if bcl6 
expression is regulated by Vax1 and Vax2 in the retina, I co-injected 3.8ng of vax1 MO 
and 3.8ng of vax2 MO (Take-uchi et al., 2003), and examined bcl6 expression at 48 hpf 
by in situ hybridization. bcl6 was not detected in the retina of vax1/vax2 morphants, 
while bcl6 was expressed in the ventral retina of control morpholino (con-MO) injected 
embryos (Figs. III-2A,B). These results indicate that Vax1 and Vax2 likely act upstream 
of bcl6 in the ventral retina. 
III. 2. 3. Knock-down of Bcl6 causes colobomas in zebrafish and Xenopus. 
To determine the function of Bcl6 in the developing eye, I performed a knock-
down analysis by injecting 7.5ng of a splice-blocking morpholino (bcl6-MO) targeting 
the bcl6 transcript. Knock-down of Bcl6 resulted in colobomas which were detected at 2 
dpf and obvious at 3 dpf, while 5 base-pair mismatch morpholino (bcl6-MMO) injected 








Figure III-1. Expression pattern of bcl6 in the zebrafish eye.  
bcl6 expression in the retina of wild-type embryos at (A)30 hpf, (B,C) 39 hpf, (D) 48 hpf, 
and (E,F) 54 hpf imaged (A,B,D,E) laterally and (C,F) ventrally. (A) bcl6 expression is 
observed in the choroid fissure at 30 hpf, and (B-F) later expands into the ventral retina. 
bcl6 expression in the optic tectum at 50 hpf imaged (G) laterally and (H) dorsally. 


















Figure III-2. Vax1 and Vax2 regulate the expression of bcl6 in the ventral retina.  
bcl6 expression in (A) con-MO injected embryos and (B) vax1&vax2 morphants at 48 

















Figure III-3. Knock-down of Bcl6 causes colobomas in zebrafish (3 dpf). 
(A,D,E) bcl6-MMO and (B,C,F-I) bcl6-MO injected embryos at 3 dpf imaged (A-D,F,H) 
laterally and (E,G,I) ventrally. Transverse histological sectioning of (J) bcl6-MMO and 
(K) bcl6-MO injected embryos. 7.5ng injection of bcl6-MO targeting bcl6 transcript 
resulted in (A-C) curved bodies and (D-K) colobomas. Dorsal is up in panels A-
D,F,H,J,K. Anterior is up in panels E,G,I. 
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bodies, suggesting that Bcl6 expressed in the somites may be required for trunk formation 
(Figs. III-3A-C). Histological analysis confirmed colobomas in bcl6-MO injected 
embryos, with retinal tissue protruding into the forebrain. Retinal lamination, and lens 
and RPE formation were normal, and all retinal cell types were present in the bcl6-MO 
injected embryos (Figs. III-3J,K). By 5dpf, colobomas in bcl6-MO injected embryos 
were more severe, with bcl6 deficient embryos possessing large holes in the posterior of 
the eye with an extrusion of retinal and RPE tissue (Figs. III-4A-F).  
To confirm that colobomas in bcl6-deficient embryos resulted from specific roles 
for Bcl6 in eye development, I designed and injected 7.5ng of a 2nd morpholino that 
targeted the translation start site of bcl6 (bcl6-MO2). bcl6-MO2 injected embryos also 
presented with colobomas, along with defects in trunk formation, and phenocopied the 
bcl6-MO injected embryos (data not shown). To further confirm that the colobomas in 
the bcl6-MO and bcl6-MO2 injected embryos are a specific phenotype from knock-down 
of Bcl6, I performed co-injection of bcl6-MO and bcl6-MO2 at sub-optimal levels (i.e. 
those that do not lead to a coloboma when injected alone). When I reduced the injection 
amount of bcl6-MO from 7.5ng to 2.5ng, no injected embryos showed colobomas or 
trunk defects. Similarly, when bcl6-MO2 was injected at 2.5ng/embryo, development was 
normal. However, co-injection of 2.5ng bcl6-MO and 2.5ng bcl6-MO2 resulted in 
colobomas in all injected embryos (n=23) (Figs. III-5A-F).  
To determine if Bcl6 function in the eye is conserved in other vertebrates, I 
applied knock-down analysis of Bcl6 in Xenopus laevis. When I injected 40ng of a 










Figure III-4. Knock-down of Bcl6 causes colobomas in zebrafish (5 dpf).  
(A-C) bcl6-MMO and (D-F) bcl6-MO injected embryos at 5dpf imaged (A,D) dorsally, 
(B,E) laterally and (C,F) ventrally. By 5dpf, (D-F) colobomas in bcl6-MO injected 
embryos are more severe, with bcl6 deficient embryos possessing large holes in the 
posterior of the eye and an extrusion of retinal and RPE tissue. Anterior is up in panels 




















Figure III-5. Knock-down of Bcl6 causes colobomas in zebrafish.  
(A,B) bcl6-MMO and (C-F) bcl6-MO & bcl6-MO2 injected embryos at 3 dpf were 
imaged laterally. Co-injection of 2.5ng bcl6-MO and 2.5ng bcl6-MO2 resulted in 










of dorsal cells at 4-cell stage, the injected side in 76% of xbcl6-MO injected embryos 
(n=25) showed colobomas and extrusion of retinal and RPE tissue into the forebrain, 
phenocopying colobomas in bcl6-MO injected zebrafish embryos (Figs. III-6A-F). Eye 
development from the un-injected side was normal. These results demonstrate that bcl6 is 
required for normal eye development in both zebrafish and Xenopus embryos 
III. 2. 4. Bcl6 prevents cell death by suppressing p53 expression in the retina. 
It has been reported that human BCL6 is involved in preventing apoptosis from 
hypermutation and chromosome rearrangement in germinal center B cells (Phan & Dalla-
Favera, 2004). To test if Bcl6 prevents apoptosis in the retina, acridine-orange staining 
was used to detect apoptotic cells in bcl6-MMO and bcl6-MO injected embryos at 48 hpf, 
a time at which there are typically no apoptotic cells in the retina of wild-type embryos 
(Cole and Ross, 2001). Indeed, bcl6-MMO injected retinas possessed no apoptotic cells 
(100%, n=22), while there were numerous apoptotic cells in the retinas of bcl6-MO 
injected embryos (71%, n=35) (Figs. III-7A,B), indicating that knock-down of Bcl6 
resulted in increased cell death in the retina.  
Given that BCL6 in germinal center B cells directly suppresses p53 expression in 
order to control apoptosis (Phan & Dalla-Favera, 2004), I investigated if Bcl6 also plays a 
role in regulating p53 expression to prevent apoptosis in the developing retina by 
examining p53 expression at 48 hpf through in situ hybridization. While p53 expression 
was nearly absent in the eye of bcl6-MMO injected embryos, there was an expansion of 











Figure III-6. Knock-down of Bcl6 causes colobomas in Xenopus.   
(A,B) con-MO and (D-F) a translation blocking morpholino targeting Xenopus bcl6 
transcripts (xbcl6-MO) injected Xenopus embryos at stage 41 were imaged (A,C) dorsally 
and (B,D) laterally. 40ng injection of xbcl6-MO results in colobomas, (A,C) an extrusion 
of retinal and RPE tissue, and (B,D) a lack of a large part of the ventral retina. Injected 














Figure III-7. Knock-down of Bcl6 resulted in increased apoptotic cells along with 
increased p53 expression in the retina. 
Acridine orange staining in (A) bcl6-MMO and (B) bcl6-MO injected embryos at 48 hpf. 
Bcl6 deficient embryos present with increased number of apoptotic cells in the retina 
(arrows in panel B). p53 expression in (C) bcl6-MMO and (D) bcl6-MO injected 
embryos at 48 hpf. p53 expression domain is observed in the retina and tectum. (E) 










expanded in the tectum (Fig. III-7D), a region that also expresses bcl6 at 48 hpf (Fig. III-
1G,H). To quantify p53 expression, qRT-PCR was performed on mRNA isolated from 
bcl6-MMO and bcl6-MO injected embryos. Comparison of p53 levels between bcl6-
MMO and bcl6-MO injected embryos after normalization by b-actin indicated that p53 
level in bcl6-MO injected embryos was 2.3 times higher than that in bcl6-MMO injected 
embryos (p<0.0001; t Test) (Fig III-7E).   
To determine if increased p53 levels were responsible for colobomas in bcl6-MO 
injected embryos, a rescue experiment was performed via knock-down of p53 with 
concurrent knock-down of Bcl6. Co-injection of 7.5ng bcl6-MO and 7.5ng bcl6-MMO 
(as a “load” control) resulted in colobomas along with curved bodies as in previous 
experiments (Figs. III-8A,B,D-G). Co-injection of 7.5ng bcl6-MO with 7.5ng p53 
morpholino (p53-MO) rescued colobomas and trunk formation (n=25) (Figs. III-8C,H,I), 
indicating that increased p53 expression may underlie colobomas in Bcl6-deficient 
embryos. These results suggest that Bcl6 functions as a regulator of apoptosis by 
controlling p53 expression in the developing eye and that Bcl6-dependent repression of 
p53 is required for normal eye development. 
III. 2. 5. Vax1 and Vax2 regulate bcl6 expression in the retina. 
Given that Vax1 and Vax2 induce the expression of bcl6 in the ventral retina 
(Figs. III-2A,B), I investigated whether vax1/vax2 morphants present with molecular 
phenotypes as well as colobomas similar to bcl6-MO injected embryos. First, p53 







Figure III-8. Co-knock-down of p53 suppresses colobomas in bcl6-MO injected 
embryos.  
(A,B,D-G) bcl6-MO injected embryos present with colobomas (arrows in panels F,G) 
and (B) curved bodies  at 3 dpf. (C,H,I) Co-injection of p53-MO with bcl6-MO 




expression in the retina of vax1/vax2 morphants at 48 hpf, while p53 expression was 
nearly absent in the eye of con-MO injected embryos (Figs. III-9A,B). To confirm the 
increased p53 expression with a quantitative analysis, qRT-PCR was performed on con-
MO injected embryos and vax1/vax2 morphants. After normalization to -actin levels, 
p53 expression levels in vax1/vax2 morphants were 4.4 times higher than that in con-MO 
injected embryos (p<0.0001; t Test) (Fig. III-9C), supporting in situ hybridization results.  
Secondly, I performed acridine-orange staining to detect apoptotic cells in the retina of 
vax1/vax2 morphants at 48 hpf. There was an increase in the number of apoptotic cells in 
the retina of vax1/vax2 morphants (68%, n=19), compared to that in con-MO injected 
embryos, which showed no apoptotic cells (100%, n=21) (Figs. III-9D,E). As previously 
reported, vax1/vax2 morphants also present with colobomas (Take-uchi et al., 2003); 
histological analysis confirmed the coloboma phenotype, revealing missing ventral retina 
tissue and holes in the posterior of the eyes (Figs. III-9H,I,K,L). These results 
demonstrate that knock-down of Vax1 and Vax2 results in a similar molecular phenotype 
to knock-down of Bcl6, including colobomas. To test if the increase in p53 expression in 
vax1/vax2 morphants is responsible for the increase of apoptotic cells and colobomas, I 
performed rescue experiments by co-knock-down of p53 along with knock-down of Vax1 
and Vax2. Interestingly, co-knock-down of p53 rescued the increased apoptotic cells as 
well as the coloboma phenotype (86%, n=22) (Figs. III-9F,J,M). These results support a 
model that Vax1 and Vax2 function as upstream regulators of bcl6 in order to control 






Figure III-9. Vax1 and Vax2 regulate bcl6 expression in the retina.  
p53 expression in (A) con-MO and (B) vax1&2-MO injected embryos at 48 hpf. (A,B) 
There is an increase of p53 expression in the retina of vax1&2-MO injected embryos, 
while p53 expression is nearly absent in the eye of con-MO injected embryos. (C) 
Quantitative anaylsis by qRT-PCR shows 4.4 fold increase in p53 levels in vax1/vax2 
morphants. Acridine orange staining in (D) con-MO and (E) vax1&2-MO injected 
embryos at 48 hpf. Vax1&2 deficient embryos present with an increased number of 
apoptotic cells in the retina (arrows in panel E). (G,I) Knock-down of Vax1 and Vax2 
results in colobomas. (K,L) Transverse histological sectioning of vax1&2-MO injected 
embryos at 3 dpf shows extrusion of retinal tissue and RPE. (F) Co-knock-down of p53 
inhibits apoptosis in vax1&2-MO injected embryos. (J,M) Colobomas is suppressed by 
co-injection of p53-MO with vax1&2-MO. 
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III. 2. 6. Bcor and Bcl6 functionally interact in the eye. 
It has been shown that several co-factors are required for Bcl6 to function as a 
transcriptional repressor (Dhordain et al., 1997; Dhordain et al., 1998; Wong and 
Privalsky, 1998), one of which is Bcor, a Bcl6 co-repressor. Bcor has been reported to be 
mutated in OFCD syndrome, a human disorder in which some patients present with 
colobomas (Ng et al. 2004; Hilton at al., 2007), and functional studies in Xenopus and 
zebrafish also support a role in suppressing colobomas (Ng et al. 2004; Hilton at al., 
2007). To test if knock-down of Bcor results in a similar phenotype on the molecular 
level to knock-down of Bcl6, p53 expression and apoptosis were examined in Bcor 
knock-down embryos. Following injection of 1ng of splice blocking morpholino 
targeting exon12/intron12 of bcor (bcor-MO), p53 expression was analyzed by in situ 
hybridization and qRT-PCR, and histological analysis was performed to determine 
morphological effects. While p53 expression was nearly absent in the eye of con-MO 
injected embryos, there was a marked increase of p53 expression in the retina of bcor-
MO injected embryos at 48 hpf (Figs. III-10A,B). qRT-PCR data revealed a 5.4 fold 
increase of p53 expression in bcor-MO injected embryos compared to that in con-MO 
injected embryos (p<0.0001; t Test) (Fig. III-10E). Acridine orange staining at 48 hpf 
demonstrated numerous scattered apoptotic cells in the retina of bcor-MO injected 
embryos, while no apoptotic cells were detected in the retina of con-MO injected 
embryos (Figs. III-10C,D). Whole mount imaging and histological analyses of bcor-MO 
injected embryos revealed severe colobomas, where a large part of the ventral retina was 






Figure III-10. Knock-down of Bcor results in the same phenotypes as knock-down of 
Bcl6.  
p53 expression in (A) con-MO and (B) bcor-MO injected embryos at 48 hpf. p53 
expression domain is extended in the retina of Bcor deficient embryos. (E) Quantitative 
anaylsis by qRT-PCR shows a 5.4 fold increase of p53 levels in bcor-MO injected 
embryos. Acridine orange staining in (D) con-MO and (E) bcor-MO injected embryos at 
48 hpf. Bcl6 deficient embryos present with an increased number of apoptotic cells in the 
retina (arrows in panel D). (F-I) Knock-down of Bcor results in colobomas (arrows in 
panel I) and shortened bodies at 3 dpf. (J,K) Transverse histological sectioning of bcor-
MO injected embryos at 3 dpf shows extrusion of retinal tissue and RPE. 
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the same molecular phenotypes as knock-down of Bcl6, suggesting that Bcor may work 
as a cofactor for Bcl6 in the developing eye. 
Previous cell culture studies that utilized B cells demonstrated that Bcor co-
immunoprecipitates with Bcl6 (Gearhart et al. 2006), suggesting that Bcor physically 
interacts with Bcl6. To investigate if Bcor functionally interacts with Bcl6 in the eye, I 
performed synergistic interaction analysis using injection of bcl6-MO and/or bcor-MO. 
To make sensitized conditions that do not lead to colobomas individually, I reduced the 
amount of bcl6-MO from 7.5ng to 1.5ng, and of bcor-MO from 1ng to 0.5ng, amounts 
that did not result in any observable phenotypes (Figs. III-11A-F). However, co-injection 
of 1.5ng bcl6-MO and 0.5ng bcor-MO resulted in colobomas and a shortened body in 
68% of injected embryos (n=31) (Figs. III-11G,H), suggesting that Bcl6 and Bcor 
functionally interact in the eye.  
III. 2. 7. Hdac1 and Bcl6 functionally interact in the eye. 
Mutations in zebrafish hdac1 result in colobomas (Yamaguchi et al., 2005; 
Stadler et al., 2005), and the transcriptional repressive function of Bcl6 requires histone 
deacetylase activity in cell culture (Bereshchenko et al., 2002). Thus, it is possible that 
Hdac1 is another co-factor required for Bcl6 to function in the eye. To test if a mutation 
in hdac1 results in similar molecular phenotypes as bcl6-MO injected embryos, I 
performed in situ hybridization to examine p53 expression and acridine orange staining to 
detect apoptotic cells as described above. Dramatic increase of p53 expression was 













Figure III-11. Bcl6 and Bcor functionally interact in the eye.  
(A,B) Wild-type embryos with normal activities of Bcl6 and Bcor develop normally. 
(C,D) Reducing the activity of Bcl6 by injecting low amounts of bcl6-MO (1.5ng) does 
not affect normal development. (E,F) Embryos injected with a low amount of bcor-MO 
(0.5ng) show normal development. (G,H) Co-injection of bcl6-MO (1.5ng) and bcor-MO 












of p53 in wild-type embryos (Figs. III-12A,B). qRT-PCR data revealed a 1.9 fold 
increase of p53 expression in hdac1 homozygous mutants compared to that in wild-type 
embryos (p<0.0001; t Test) (Fig. III-12C). hdac1 mutants also presented with scattered 
apoptotic cells in the retina, while no apoptotic cells were detected in wild-type embryos 
at 48 hpf (Figs. III-12E,F). These data indicate that loss of Hdac1 function causes similar 
molecular phenotype to loss of Bcl6 function. 
To investigate if Hdac1 functions with Bcl6, I performed a similar synergistic 
interaction analysis using bcl6-MO injection and Trichostatin-A (TSA) treatment. TSA is 
a chemical inhibitor of histone deacetylase activity and previous studies have shown that 
TSA treatment recapitulates the coloboma phenotype in hdac1 homozygous mutants 
(Yamaguchi et al., 2005). I utilized sensitized conditions of Hdac1 activity which do not 
lead to any phenotypes (including colobomas) by reducing the concentration of TSA to 
700nM and treating at a later time point (24 hpf). The embryos treated with TSA at this 
sub-optimal level developed normally (Figs III-13A-D). When I reduced the injection 
amount of bcl6-MO from 7.5ng to 2ng, the injected embryos didn’t present with any 
detectable phenotypes (Figs. III-13E,F). However, when I treated 2ng bcl6-MO injected 
embryos with 700nM TSA from 24 hpf to 72 hpf, the embryos presented with colobomas 
and curved body (81%, n=27), similar to the hdac1 and bcl6-MO phenotype (Figs. III-












Figure III-12. Mutation in hdac1 results in the same molecular phenotypes as 
knock-down of Bcl6.  
p53 expression in (A) wild-type and (B) hdac1 mutants embryos at 48 hpf. p53 
expression domain is extended in the retina of hdac1 mutants. (C) Quantitative analysis 
by qRT-PCR shows a 1.9 fold increase of p53 levels in hdac1 mutants. Acridine orange 
staining in (D) wild-type and (E) hdac1 mutants embryos at 48 hpf. hdac1 mutants 






















Figure III-13. Bcl6 and Hdac1 functionally interact in the eye.  
(A,B) Wild-type embryos with full activities of Bcl6 and Hdac1 develop normally. (C,D) 
Embryos treated with a low concentration of TSA (700nM) show normal development. 
(E,F) Reduced activity of Bcl6 by injection of a low amount of bcl6-MO (1.5ng) does not 
affect normal development. (G,H,H’) Treatment of TSA (700nM) into the embryos 




III. 2. 8. Bcor and Hdac1 functionally interact in the eye. 
Since Bcor and Hdac1 are cofactors that functionally interact with Bcl6, it is 
plausible that Bcor and Hdac1 also functionally interact with each other. In cell culture, 
there was evidence that Bcor physically binds to Hdac1 (Huynh et al., 2000), supporting 
the possibility that they might works together in the eye. I performed a similar synergistic 
interaction analysis with bcor-MO injection and TSA treatment as previous interaction 
analyses. I utilized sensitized conditions of Hdac1 activity which do not lead to any 
phenotypes (including colobomas) by reducing the concentration of TSA to 500nM and 
treating at a later time point (24 hpf). The embryos treated with TSA at this sub-optimal 
level developed normally (Figs. III-14A-D). When I reduced the injection amount of 
bcor-MO from 1.0ng to 0.5ng, the injected embryos didn’t present with any detectable 
phenotypes (Figs. III-14E,F). However, when I treated 0.5ng bcor-MO injected embryos 
with 500nM TSA from 24 hpf to 72 hpf, the embryos presented with colobmas and 
curved body as in hdac1 homozygous mutants and 1.0ng bcor-MO injected embryos 
(86%, n=29) (Figs. III-14G,H,H’).  
To further confirm the functional interaction between Bcor and Hdac1, I 
performed a second interaction analysis by injecting 0.5ng of bcor-MO into hdac1 
heterozygous embryos. In the hdac1 heterozygous embryos, loss of Hdac1 activity by 
half is not enough to cause developmental defects like coloboma, thus can be considered 
as another sensitized condition especially for Hdac1. As in the previous experiment, the 
wild-type embryos injected with 0.5ng of bcor-MO developed normally. But when I 








Figure III-14. Bcor and Hdac1 functionally interact in the eye.  
(A,B) Wild-type embryos with full activities of Bcor and Hdac1 develop normally. (C,D) 
Embryos treated with a low concentration of TSA (500nM) show normal development. 
(E,F) Reduced activity of Bcor by injection of a low amount of bcor-MO (0.5ng) does 
not affect normal development. (G,H,H’) TSA (500nM) Treatment of bcor-MO (0.5ng) 
injected embryos results in colobomas (arrow in panel H) and curved bodies. (I) Injection 
of bcor-MO (0.5ng) into wild-type siblings does not have any effect on normal 




hdac1 heterozygote male and wild-type female, which were theoretically expected as the 
mixture of 50% heterozygotes and 50% wild-type siblings, 47.7% of the injected 
embryos showed colobomas in the eye and shortened body phenotypes (Figs. III-14I,J). 
In addition, genotyping of 5 embryos with colobomas confirmed that all of them were 
hdac1 heterozygotes. These results support a model in which Hdac1 has a functional 
interaction with Bcor to regulate eye formation.    
III. 3. DISCUSSION 
In this study, I elucidated the function and regulation of Bcl6, a transcriptional 
repressor, in the developing zebrafish eye. Loss of Bcl6 function resulted in colobomas 
and ventral retina defects, demonstrating that Bcl6 plays a critical role in preventing 
apoptosis in the retina during eye development, and this is required to contain the retina 
and RPE within the optic cup. I also showed that Vax1 and Vax2 act upstream of bcl6 in 
the ventral retina, and Bcl6 functions along with Bcor and Hdac1 to mediate cell survival 
by regulating p53 within the developing zebrafish retina (Fig. III-15). 
III. 3. 1. Knock-down of Bcl6 results in colobomas in developing zebrafish eyes. 
Morpholino knock-down analysis performed in zebrafish embryos demonstrates 
that loss of Bcl6 function results in ocular colobomas with defects in trunk formation. 
Given that there was a report that the knock-down technology using MO injection has 
possibility to cause off-target effects, mainly neural cell death through p53 activation 
(Robu et al., 2007), I confirmed that colobomas in bcl6-MO injected embryos resulted 












Figure III-15. Schematic diagram of the role of Bcl6 in CF closure.  
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embryos did not show smaller heads and eyes which usually result from neural cell death 
by off-target effects of MO. Histological analysis revealed that there was no disrupted 
retinal lamination and missing retinal cell types other than the colobomas. Secondly, a 5 
base-pair mismatch MO designed within the bcl6-MO sequence did not have any effects 
on development at even higher injection amount than that of bcl6-MO. Thirdly, in 
addition to the splice blocking MO (bcl6-MO), I designed another MO (bcl6-MO2) that 
blocks translation of bcl6 mRNA, and bcl6-MO2 injected embryos presented with similar 
phenotypes to bcl6-MO injected embryos. Since the neural death from non-specific 
effects is dependent on MO sequences (Robu et al., 2007), it is unlikely that two different 
MO sequences targeting the same gene would cause neural death; indeed, the similar 
results from two different MOs support that colobomas in the morphants are a specific 
phenotype resulting from loss of Bcl6 function. Furthermore, co-injection of bcl6-MO 
and bcl6-MO2 at sub-threshold levels resulted in colobomas. Moreover, knock-down of 
Bcl6 in another organism, Xenopus, phenocopied colobomas in Bcl6 knock-down 
zebrafish embryos. These results demonstrate that roles of Bcl6 in eye development are 
conserved between zebrafish and Xenopus, and that Bcl6 functions in preventing 
colobomas in the ventral retina. Finally, previous studies have shown that knock-down of 
Bcor, a co-repressor of Bcl6, results in a similar coloboma phenotype to Bcl6 knock-
down in both zebrafish and Xenopus (Ng et al., 2004; Hilton et al., 2007), which further 
supports a model in which Bcl6 is required in the vertebrate eye for normal development. 
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III. 3. 2. Bcl6 is involved in regulating apoptosis in the eyes. 
 The function of BCL6 has been largely studied in B cells and is known to play a 
critical role in formation of germinal center and survival of B cells in germinal center 
(Dent et al., 1997). Given that the deregulation of Bcl6 from chromosomal rearrangement 
or point mutations in the 5’ non-coding region is found in certain types of lymphomas 
(Ohno, 2004; Pasqualucci et al., 2003; Ye et al., 1995; Migliazza et al., 1995), regulation 
of BCL6 expression is deeply involved in controlling cell death and proliferation. In 
germinal center B cells, BCL6 inhibits p53 expression induced by DNA damage caused 
by immunoglobulin class switching and somatic hypermutation, thus allowing B cells to 
survive (Phan and Dalla-Favera, 2004). In bcl6-MO injected embryos, p53 expression is 
significantly increased along with increased cell death in the retina. Like in B cells, these 
results suggest that Bcl6 functions in the zebrafish retina to control apoptosis by 
suppressing p53 expression. In many cell types that express Bcl6 (i.e. mammary 
epithelial cells and cells in the nervous system), terminal differentiation may be achieved 
by preventing apoptosis (Bajalica-Lagercrantz et al., 1998; Funatsu et al., 2004; Leamey 
et al., 2008; Logarajah et al., 2003; Otaki et al., 2005). Recently, it has been reported that 
BCL6 plays an important role in survival of differentiating olfactory sensory neurons 
(Otaki et al., 2010). Given that cells in the developing retina are in the process of 
differentiating, Bcl6 may work as an anti-apoptotic factor, allowing them enough time to 
differentiate. A previous study of apoptosis in the zebrafish retina showed that the 
number of apoptotic cells abruptly starts to increase after 30 hpf, peaks at 36 hpf, and 
drops dramatically before 48 hpf (Cole and Ross., 2001). My results make it plausible 
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that Bcl6 expressed in the retina may play an important role in controlling apopotosis by 
suppressing p53 expression during this period. 
III. 3. 3. Vax1 and Vax2 act upstream of bcl6. 
In this study, I showed that loss of Vax1 and Vax2 resulted in a loss of bcl6 
expression, concomitant with induction of p53, and an increase in the number of 
apoptotic cells in the eye, suggesting that Vax1 and Vax2 act upstream of bcl6 to regulate 
cell survival in the retina. Interestingly, co-knock-down of p53 along with Vax1/Vax2 
rescued colobomas in vax1/vax2 morphants, as in Bcl6 deficient embryos, providing 
further support that Vax1/Vax2 function upstream of bcl6 during retina development. 
Previous studies in mouse lacking of Vax1 or Vax2 function revealed that defects in 
choroid fissure closure stemmed from a failure to restrict retinal cell fates to the optic cup 
(Barbieri et al., 2002; Bertuzzi et al., 1999; Hallonet et al., 1999; Mui et al., 2002). In 
zebrafish vax1/vax2 morphants, a failure of choroid fissure closure was thought to result 
from cell fate changes in optic vesicle, causing an expansion of retina cell fates into optic 
nerve region (Take-uchi et al., 2003), which is a similar phenotype to that in the mouse 
knock-out. Here, I provided another possible mechanism by which Vax1/Vax2 may be 
required during eye development, which is in the control of apoptosis by regulating bcl6 
expression.  
III. 3. 4. Bcl6 functionally interacts with Bcor and Hdac1. 
Mutations in BCOR, a BCL6 corepressor, are known to be responsible for OFCD 
syndrome whose defects include ocular disease like microphthalmia and colobomas (Ng 
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et al., 2004; Gorlin et al., 1996; Schulze et al., 1999; Hedera and Gorski, 2003). Loss of 
function studies using knock-down of zebrafish Bcor recapitulated human OFCD 
syndrome with colobomas (Ng et al., 2004). Evidence from cell culture studies 
demonstrate that Bcl6 interacts with Bcor through its POZ/BTB domain and recruits Bcor 
with other corepressors to Bcl6 target genes like p53 and cyclin D2 (Gearheart et al., 
2006). Left-right asymmetry patterning studies in Xenopus provided in vivo evidence 
supporting the possibility that Bcl6 functionally interacts with Bcor (Hilton et al., 2007; 
Sakano et al., 2010). Loss of function studies using MO knock-down technology for both 
Bcl6 and Bcor in Xenopus showed similar laterality defects like reversion of cardiac 
orientation and disorganized gut patterning as well as a similar molecular phenotype of 
down-regulation of Pitx2 expression. My results from synergistic interaction analysis of 
Bcl6 and Bcor provided further in vivo evidence that Bcl6 and Bcor are functionally 
associated with each other, and this is required for normal eye development. 
Interestingly, colobomas resulting from either Bcl6 or Bcor knock-down in Xenopus 
resemble each other, suggesting that functional interaction of Bcl6 and Bcor plays an 
important role in the eye development of Xenopus as well.  
Histone deacetylases (HDACs) are known to be involved in silencing 
transcription through epigenetic modification of histones, maintaining a transcriptionally 
inactive chromatin state (Sterner and Berger, 2000), or through directly regulating 
activity of transcription activators with controlling their cytosol/nuclear localization, 
affinities with co-factors, or abilities to bind DNA (Barlev et al., 2001). It has been 
reported that acetylation of BCL6 by p300 inactivate its function as a transcription 
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repressor and prevents recruiting co-factor complex including HDACs (Bereshchenko et 
al., 2002). Furthermore, studies using zebrafish hdac1 homozygous mutants revealed that 
Hdac1 plays an important role in cell cycle exit and differentiation in the retina, and that 
loss of Hdac1 function results in severe colobomas (Stadler et al., 2005; Yamajuchi et al., 
2005). In the developing mouse retina, HDAC activity is involved in regulating 
expression of the pro-apoptotic factors like Apaf-1 and Caspase3 in order to prevent 
apoptosis (Wallace and Cotter, 2008; Wallace et al., 2006). My results showed that hdac1 
homozygous mutants present with similar phenotypes to bcl6 deficient embryos, showing 
up-regulation of p53 expression and increased number of apoptotic cells in the retina. 
These data suggest that BCL6 and HDACs might functionally interact with each other in 
the eyes. My synergistic interaction analysis showed that reduced activities of both Bcl6 
and Hdac results in colobomas, while reduction of each of these alone did not affect eye 
development, demonstrating that Bcl6 functionally interacts with Hdac in the developing 
eye. 
In addition, synergistic interaction analysis for Bcor and Hdac1 revealed that Bcor 
and Hdac1 are also functionally associated in the eye. Previous co-immunoprecipitation 
studies revealed that Hdac physically interact with Bcor (Huynh et al., 2000), supporting 
the cooperation of Bcor and Hdac1in the eye demonstrated here through functional 
analysis.  
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III. 3. 5. Possible molecular mechanisms by which Bcl6 functions during eye 
development. 
 Although the function, the target genes, and corepressors of Bcl6 have been 
studied in various contexts, the molecular mechanisms by which Bcl6 suppresses 
transcription remain to be elucidated. Intensive co-immunoprecipitation studies on 
associating partners for Bcl6 in cell culture systems provided a couple of possible 
mechanisms regulating transcription of target genes. It has been reported that a 
transcriptional repression complex, called the BCOR complex, includes FBXL10 and 
Polycomb group proteins, which are known to suppress transcription through epigenetic 
modification of chromatin, and that this complex is recruited by BCL6 to target genes 
(Gearheart et al., 2006). Furthermore, one of the Polycomb group components, RNF2, 
possesses E3 ligase activity and could mono-ubiquitinate H2A. Since mono-ubiquitylated 
H2A is considered to maintain a repressed state of chromatin, Bcl6 in recruiting the 
BCOR complex to target gene promoters, may recruit RNF2 in order to suppress 
transcription; indeed, enriched mono-ubiquitylated H2A was found at BCL6 target genes 
(Cyclin D2 and p53) in B cells (Gearheart et al., 2006). Demethylation of H3 K36 
through FBXL10, another BCOR complex member, is another possible mechanism 
underlying Bcl6-dependent repression. Methylation of H3 K36 is considered to promote 
transcription and FBXL10 possesses a JmjC demethylase domain, which is expected to 
specifically demethylate di-methylated H3 K36 (Tsukada et al., 2006; Bannister et al., 
2005; Rao et al., 2005), suggesting FBXL10 may function to epigenetically repress 
transcription. Given that FBXL10 can be recruited as a component of Bcor complex to 
 78 
Bcl6 target genes, Bcl6 may utilize the demethylase activity of FBXL10 to suppress 
transcription. Since BCOR associates with HDACs in mammalian cell culture (Huynh et 
al., 2000), Bcl6 can also bring Hdacs to target genes. Loss of Hdacl function in zebrafish 
embryos showed highly increased acetylation of histone H4 as well as apoptotic cells, 
resulting in colobomas (Stadler et al., 2005). And I showed that Bcor interacts genetically 
with Hdac1 in zebrafish. Thus, it is also plausible that the deacetylation of histones 
through Hdac1 may repress transcription of Bcl6 target genes. Future work will test these 
models and determine the mechanisms underlying Bcl6/Bcor function in regulating cell 





SUMMARY AND CONCLUSION 
 
During optic cup morphogenesis, the neuroectodermal layers of the OV 
invaginate ventrally, and fuse at the choroid fissure along the proximo-distal axis such 
that the retina and RPE are confined within the cup. Failure of the choroid fissure to 
properly close during early eye development causes ocular malformations called 
colobomas, which are characterized by the persistence of a cleft or hole at the back of the 
eye, resulting in blindness. While choroid fissure closure is a critical aspect of ocular 
development, the molecular and cellular mechanisms underlying this process are poorly 
understood. During my Ph.D. research, I have focused on addressing molecular 
mechanisms underlying choroid fissure closure and colobomas. 
In the first of my studies, I determined that early cell fate changes within the eye 
field could be responsible for choroid fissure closure defects that lead to colobomas (Lee 
et al., 2008). In this study I have characterized the ocular defects in the recessive 
zebrafish mutant blowout that presents with a variably penetrant coloboma phenotype. 
blowout mutants develop unilateral or bilateral colobomas and as a result, the retina and 
retinal pigmented epithelium are not contained within the optic cup. Colobomas result 
from defects in optic stalk morphogenesis whereby the optic stalk extends into the retina 
and impedes the lateral edges of the choroid fissure from meeting and fusing. The 
expression domain of the proximal optic vesicle marker pax2a is expanded in blowout at 
the expense of the distal optic vesicle marker pax6, suggesting that the initial patterning 
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of the optic vesicle into proximal and distal territories is disrupted in blowout. Later 
aspects of distal optic cup formation (i.e. retina development) are normal in blowout 
mutants, however. Positional cloning of blowout identified a nonsense mutation in 
patched1, a negative regulator of the Hedgehog pathway, as the underlying cause of the 
blowout phenotype. Expanded domains of expression of the Hedgehog target genes 
patched1 and patched2 were observed in blowout, consistent with a loss of Patched1 
function and upregulation of Hedgehog pathway activity. Moreover, colobomas in 
blowout could be suppressed by pharmacologically inhibiting the Hedgehog pathway 
with cyclopamine, and maximal rescue occurred when embryos were exposed to 
cyclopamine between 5.5 and 13 hours post fertilization. These observations highlight the 
critical role that Hedgehog pathway activity plays in mediating patterning of the 
proximal/distal axis of the optic vesicle during the early phases of eye development and 
they provide genetic confirmation for the integral role that patched1-mediated negative 
regulation of Hedgehog signaling plays during vertebrate eye development. 
In the second of my studies, I examined Bcl6 function and regulation during 
vertebrate eye development. bcl6 encodes a transcriptional repressor expressed in the 
ventral retina during zebrafish eye development. Human BCL6 is involved in cell 
survival and cell cycle regulation in germinal center B cells, however, roles for Bcl6 in 
the eye have not been identified. Loss of Bcl6 function leads to colobomas and ventral 
retina defects. The role for Bcl6 in the eye is also conserved in Xenopus. bcl6 knockdown 
also results in up-regulation of p53, a previously known Bcl6 target, and an increase in 
the number of apoptotic cells in the retina. Knockdown of both bcl6 and p53 prevents 
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colobomas supporting a model in which Bcl6 dependent p53 inhibition in the retina is 
required for cell survival therein. These results demonstrate that Bcl6 plays a critical role 
in preventing apoptosis in the retina during eye development, and this is required to 
contain the retina and RPE within the optic cup. Loss of Vax1 and Vax2 in zebrafish 
leads to colobomas (Take-uchi et al., 2003), and I tested whether Vax1 and Vax2 act 
upstream of bcl6. Indeed, loss of Vax1 and Vax2 resulted in a loss of bcl6 expression, 
concomitant with induction of p53, and an increase in the number of apoptotic cells in the 
eye. Interestingly, triple knockdown of vax1, vax2 and p53 rescued colobomas in 
vax1/vax2 morphants suggesting that Vax1 and Vax2 act upstream of bcl6 to regulate cell 
survival in the retina. Finally, I identified functional interactions between Bcl6, Bcor and 
Hdac1 during eye development, suggesting that Bcl6 functions along with Bcor and 
Hdac1 to mediate cell survival by regulating p53 within the developing zebrafish retina.  
Combined, my studies expand the gene regulatory network involved in cell fate 
determination and cell survival during CF closure and ventral retina formation, and 
provide mechanistic insight into coloboma formation (Fig. IV-1) and they will further our 
ability to identify and develop possible therapies for colobomas, enabling the patients to 











Figure IV-1. Gene regulatory network underlying ventral retina formation and 
choroid fissure closure.  
In this schematic diagram, my research findings are highlighted by red lines and light 
blue backgrounds.   
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Appendix A : Materials and Methods 
A.1. ZEBRAFISH MAINTENANCE AND STRAINS 
Zebrafish (Danio rerio) were maintained at 28.5°C on a 14h light/10h dark cycle. 
Embryos were obtained from the natural spawning of heterozygous carriers or 
homozygous mutants setup in pairwise crosses. Embryos were collected and raised at 
28.5°C after Westerfield (1995) and were staged according to Kimmel et al. (1995). 
blw
tc294z
 outcrosses were provided by Dr. Hans Georg Frohnhöfer at the Max Planck 
Institute for Developmental Biology and were propagated by repeated outcrosses to TL 
fish. hdac1
hi1618Tg
 outcrosses were provided by Zebrafish International Resource Center 
(ZIRC) at the University of Oregon and were propagated by repeated outcrosses to AB 
fish. All animals were treated in accordance with provisions established at the University 
of Texas at Austin governing animal use and care.  
A.2. HISTOLOGY 
Histology was performed as described in Nuckels and Gross (2007). Briefly, 
embryos were collected and fixed overnight at 4°C in a solution of 1% (w/v) 
paraformaldehyde (PFA), 2.5% glutaraldehyde and 3% sucrose in phosphate buffered 
saline (PBS). They were washed 3 × 5 minutes (min) in PBS and re-fixed for 90 min at 
4°C in a 2% OsO4 solution, washed 3 × 5 min in PBS at room temperature (RT) and 
dehydrated through a graded ethanol series (50, 70, 80, 90, 2 × 100%). Embryos were 
further dehydrated 2 × 10 min in propylene oxide and infiltrated 1–2 hours in a 50% 
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propylene oxide/50% Epon/Araldite mixture (Polysciences, Inc.). Embryos were then 
incubated overnight at RT in 100% Epon/Araldite resin with caps open to allow for 
propylene oxide evaporation and resin infiltration, embedded and baked at 60°C for 2–3 
days. Sections 1–1.25 um were cut, mounted on glass slides and stained in a 1% 
methylene blue/1% borax solution. Sections were mounted in DPX (Electron Microscopy 
Sciences) and photographed on a Leica DMRB microscope mounted with a DFC320 
digital camera. 
A.3. IMMUNOHISTOCHEMISTRY 
Laminin immunohistochemistry was performed as described in Lee and Gross 
(2007). Briefly, embryos were collected and fixed overnight at 4°C in a solution of 4% 
PFA and 3% sucrose in PBS. Embryos were washed at RT 3 × 5 min in PBS and 
processed immediately for whole mount immunohistochemistry. Whole-mount embryos 
were washed in PBS/0.1% TIen-20 (PBST) and permeabilized 12’ with 100% acetone 
prechilled to −20°C. Embryos were washed three times at RT with PBST and digested 
with proteinase K (10ug/mL diluted in PBST) for 12–30 minutes depending on age. 
Embryos were then washed with PBST, refixed in 4% PFA for 10’ at RT, washed 3x in 
PBST and blocked for 1 hour at RT in block [2% normal goat serum (NGS), 1% DMSO 
in PBST]. Embryos were then incubated overnight at 4°C in anti-laminin-111 antibody 
(Sigma) diluted 1:400 in block. Embryos were washed 5x 30’ in PBST and incubated 
overnight at 4°C in biotin-SP conjugated affinity purified F(ab’)2 goat anti-rabbit IgG 
diluted 1:500 in block. Embryos were then washed 5x 30’ in PBST and incubated 3 hours 
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at RT in Avidin-Peroxidase Complex Reagent (ABC Reagent; Vector Labs). Embryos 
were washed 3x 30’ in PBST and then developed for 10–30’ with DAB reagent (Sigma). 
After development, embryos were fixed briefly in 4%PFA, cryosectioned and imaged as 
above. Immunohistochemistry with zpr1, zpr3 and zn8 monoclonal antibodies (Zebrafish 
International Resource Center) was performed as described in Uribe and Gross (2007). 
Primary antibodies were diluted at 1:200, Cy3 secondary antibody at 1:300 and Sytox-
Green (Molecular Probes) at 1:10,000. Imaging was performed on a Zeiss LSM5 Pascal 
laser scanning confocal microscope. 3–5 optical sections (1um in thickness) were 
collected and projected using Zeiss confocal software. Images were overlaid using Adobe 
Photoshop CS2. 
A.4. 5-BROMO-2-DEOXYURIDINE (BRDU) STAINING 
Embryos were dechorionated and incubated in fish water with 10mM BrdU 
(Sigma) for defined time periods and either immediately sacrificed or washed three times 
into fish water and grown for additional periods before sacrifice. Embryos were 
processed for immunohistochemistry after Uribe and Gross (2007) with the addition of a 
10 min incubation in 4N HCl at 37° prior to blocking to relax chromatin and facilitate 
BrdU detection. Mouse anti-BrdU was used at a 1:50 dilution and Cy3 anti-mouse 
secondaries were used at a 1:200 dilution. Nuclei were counterstained with Sytox-Green 
(1:10,000; Molecular Probes). Imaging was performed on a Zeiss LSM5 Pascal laser 
scanning confocal microscope. 3–5 optical sections (1um in thickness) were collected and 
projected using Zeiss confocal software. BrdU positive cells and nuclei were counted in 
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three to five eyes from different embryos and averages were compared by Fisher’s exact 
test for statistical significance (Graphpad Prism). 
A.5. POSITIONAL CLONING 
Mapping was essentially performed as in (Willer et al., 2005). A mapping panel 
was generated by outcrossing a TL+/blw with a WIK +/+ fish and then backcrossing a 
resulting WIK+/blw male with a TL+/blw female. Genomic DNA was isolated from 
homozygous embryos and wild-type siblings and used for bulk segregant analysis. 
Simple sequence length polymorphisms (SSLPs) roughly 20cM apart across the genome 
were amplified by PCR and analyzed on E-Gel 4% agarose gels (Invitrogen). Once 
linkage was detected, 96 individual mutants were genotyped to confirm linkage and 
refine the interval. For high-resolution mapping, new mapping panels were created by 
backcrossing two individual WIK+/blw females to TL+/blw males to create homozygous 
mutants. Flanking markers Z11410 and Z13521 were used to genotype a total of 526 
mutant embryos. The Ensembl Zv6 Zebrafish assembly was used to identify completed 
BAC sequences in the interval and new markers were designed within these BACs using 
the Zebrafish SSR search website (http://danio.mgh.harvard.edu/markers/ssr.html). A 
917kb critical interval was identified and the open reading frames (ORFs) from six 
candidate loci in the interval were cloned and sequenced from blw and wild-type embryos 
using Big-Dye chemistry and an ABI 3130XL DNA sequencer (Applied Biosystems). 
Mutations in atp6v0b (NM_199561) and ptc1 (NM_130988) were identified. A ptc1 
mutation in blw was first reported by Koudijs et al., (2008). Confirmation of the 
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identified T→A mutation at position 520 in atp6v0b was obtained by genotyping 
genomic DNA from mutant, WIK+/blw, and TL+/blw fish using a SNP assay run on a 
PSQ HS 96 Pyrosequencer (Biotage AB). Confirmation of the identified G→A mutation 
at position 3119 in ptc1 was obtained by PCR amplifying the corresponding region of 
genomic DNA from mutant, WIK+/blw and TL+/blw fish and then direct sequencing. 
G3119A also disrupts a conserved AvaII restriction site enabling blw mutants to be 
genotyped by restriction fragment length polymorphism (RFLP) assays where genomic 
DNA was isolated from embryos and a region of the ptc1 gene from Exon 16 (5' - CCA 
TGA TAA GTA CGA CAC CAC TGG AGA G - 3') to Intron 17 (5' - CAC TAC ACC 
AAA TCC CTG ATG GAT GG - 3') spanning the mutation was PCR amplified, gel 
purified, digested overnight with AvaII and analyzed on a 2% agarose gel. 
A.6. MORPHOLINO, MRNA AND BAC INJECTIONS 
ptc1, atp6v0b, vax1, and vax2 morpholinos (MOs) were purchased from Open 
Biosystems (Huntsville, AL). bcl6-MO, bcl6-MMO, bcor-MO, and p53-MO were 
purchased from Gene Tools (Philomath, OR). MOs were resuspended in water and 
injections performed at the 1-cell stage into wild-type Oregon AB embryos. A standard 
control morpholino (5’-CCTCTTACCTCAGTTACAATTTATA-3’) was used for 
injection control embryos and 13ng was injected. Ptc1MO (5′-
CATAGTCCAAACGGGAGGCAGAAGA-3') targeted the translation initiation site of 
the ptc1 transcript (Wolff et al., 2003) and 1.3 ng was injected into 1-cell stage wild-type 
Oregon AB embryos. atp6v0b MO (5'-AAGGTTTTATTAGCACTTACCGACG-3’) 
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targeted the exon1/intron1 junction of the atp6v0b transcript and 13 ng was injected into 
1-cell stage wild-type Oregon AB embryos. Splicing was verified by RT-PCR as 
described in (Gross and Dowling, 2005). Bcl6-MO (5′-
GCAAGCAGCCTTCAATTGTACCTGC-3') targeted the exon2/intron2 junction of the 
bcl6 transcript and 7.5 ng was injected into 1-cell stage wild-type Oregon AB embryos. 
bcor-MO (Ng et al., 2004) targeted the exon12/intron12 junction of the bcor transcript 
and 1.0 ng was injected into 1-cell stage wild-type Oregon AB embryos. vax1-MO 
(3.7ng) and vax2-MO (3.7ng) (Take-uchi et al., 2003) was injected into 1-cell stage wild-
type Oregon AB embryos. For mRNA overexpression, full-length ptc1 was PCR 
amplified and subcloned into pCR4-TOPO, and atp6v0b and atp6v0b
N113K
 were PCR 
amplified and subcloned into pCS2. Plasmid containing cDNAs were linearized and used 
for in vitro translation (mMessage Machine, Ambion). mRNA was resuspended in water 









crosses and/or 1-cell stage wild-type Oregon AB embryos. BAC DKEY-31M5 was 
purchased from RZPD (Berlin, Germany), isolated from bacteria (Qiagen) and injected 
into 1-cell stage embryos derived from heterozygous blw incrosses. 
A.7. RIBOPROBES AND IN SITU HYBRIDIZATION  
Hybridizations were performed essentially as described by JoItt and Lettice using 
digoxigenin labeled antisense RNA probes (JoItt and Lettice, 1994). ptc1 and p53 was 
cloned from 24hpf cDNA, ligated into pGEM-T and used for probe synthesis (cloning 
details available upon request). In situ hybridizations on embryos younger than 48hpf 
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was performed on embryos derived from homozygous incrosses such that all embryos 
were mutant and genotyping was unnecessary. Probe synthesis constructs for the listed 
genes were generously provided by the following researchers: pax2a (Bruce Riley, Texas 
A+M University), ptc2 (Brian Perkins, Texas A+M University), pax6 (Brian Link, 
Medical College of Wisconsin), and bcl6 (Zebrafish International Resource Center). 
A.8. CYCLOPAMINE AND TRICHOSTATIN A (TSA) TREATMENTS 
Cyclopamine (Sigma) was resuspended at 10mg/mL in 100% ethanol and diluted 
into fish water for exposures. 100% ethanol was used for vehicle controls. Embryos 
derived from homozygous blw incrosses were used for all exposures. Embryos were 
removed from cyclopamine at defined times and washed into fish water for further 
culturing. Cyclopamine rescue data was analyzed by Fisher’s exact test for statistical 
significance (Graphpad Prism). 
TSA stock solution (Sigma, 1 mg/ml in DMSO) was diluted to appropriate 
concentrations for use. Embryos were incubated in TSA-containing fish water from 24 
hpf to 72 hpf and immediately fixed with 4% PFA. 
A.9. PREPARATION OF XENOPUS EMBRYOS AND MORPHOLINO INJECTION 
Xenopus laevis embryos were de-jellied using a 3% cysteine solution in 1/3X 
MMR. Anti-sense morpholino oligonucleotides for Bcl6 (Sakano et al., 2010) was 
injected into one of dorsal cells at the 4 cell stage and were incubated until proper 
developmental stage (Nieuwkoop and Faber, 1994). The injected embryos were fixed at 
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stage 41 with 1X MEMFA (0.1 M MOPS, 2 mM EGTA, 1 mM MgSO4, 3.7% 
formaldehyde, pH 7.4).  
A.10. QUANTITATIVE REAL-TIME RT-PCR (QRT-PCR) 
Total RNA was also extracted from con-MO injected, bcl6-MO injected, bcor-
MO injected, or vax1/vax2 MO injected, or hdac1 homozygous mutants embryos at 48 
hpf using TRIzol reagent (Invitrogen). The total RNA was reverse-transcribed using 
iScript
TM 
cDNA Synthesis Kit (BIO-RAD). Relative gene expression levels were 
quantified using Power SYBR Green dye (Applied Biosystems) and an ABI PRISM 
7900HT real-time PCR cycler (ABI SDS 2.3 software). All samples were analyzed in 
triplicate and relative transcript abundance was normalized to expression of -actin using 
the 2 (-delta delta C(T)) method (Livak and Schmittgen, 2001). Primers used to assay 
gene expression were designed across exon boundaries of p53. Primers were as follows: 
p53 forward 5’-CCC ATC CTC ACA ATC ATC ACT CTG G-3’, reverse 5’-TCT CCT 
CAG TTT TCC TGT CTC TGC C-3’; -actin forward 5’- CCA AAG CCA ACA GAG 
AGA AGA TGA C-3’, reverse 5’- TAC AGA GAG AGC ACA GCC TGG ATG -3’; 
A.11. ACRIDINE ORANGE STAINING 
Embryos were incubated for 30 min in fish water with 5 μg/ml acridine orange 
(Sigma). The embryos were washed three times for 5 min in fish water. The embryos 
were then anaesthetized and Fluorescence signal was detecteded immediately under a 
fluorescence microscope using a rhodamine filter set.  
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